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ABSTRACT
Identification of Novel Virulence Genes of Salmonella enterica Using an Array Based
Analysis of Cistrons Under Selection.  (May 2010)
Mollie Megan Reynolds, B.S., Texas A&M University
Chair of Advisory Committee: Dr. Helene Andrews-Polymenis
Pools of mutants of minimal complexity but maximal coverage of genes of
interest facilitate screening for genes under selection in a particular environment. Prior to
this work, mutants were generated by random transposon insertions, which yielded
highly complex pools for in vivo studies. Recent advances in polymerase chain reaction
(PCR)-based mutagenesis in bacteria using the lambda red recombinase, as well as
whole genome sequencing, enable a more directed approach for the generation of
mutants. The lambda red approach was used to construct individual mutants in 1,023
Salmonella enterica serovar Typhimurium genes, including almost all genes found in
Salmonella, but not in related genera. All the mutations were confirmed simultaneously
using a novel amplification strategy to produce labeled ribonucleic acid (RNA) from a
T7 RNA polymerase promoter, introduced during the construction of each mutant,
followed by hybridization of this labeled RNA to a Typhimurium genome tiling array.
To demonstrate the ability to identify fitness phenotypes using our pool of mutants, the
pool was subjected to selection by intraperitoneal injection into BALB/c (Bagg Albino)
mice and was recovered from the spleen. Changes in the representation of each mutant
iv
were monitored using T7 transcripts hybridized to a novel inexpensive minimal
microarray. Among the top 120 statistically significant spleen colonization phenotypes,
51 were mutations in genes with no previously known role in this model. Fifteen
phenotypes were tested using individual mutants in competitive assays and eleven were
confirmed in individual mixed intraperitoneal infection in mice, including the first two
examples of attenuation for sRNA mutants in Salmonella. We refer to our method as
Array-Based Analysis of Cistrons Under Selection (ABACUS).
Among the confirmed mutants identified in the ABACUS screen was a
component of the twin arginine transport (Tat) system, tatC, required for transport of
folded proteins across the cellular membrane. TatC is the highly conserved component
necessary for recognition of the twin arginine containing signal sequence S/T-R-R-x-F-
L-K. We confirmed ΔtatC mutants are defective for colonization of the liver and spleen
in competitive infections with wild type ATCC14028 after intraperitoneal infection in
Salmonella- susceptible (BALB/c). We also found that ΔtatC mutants were defective for
swimming motility, but not swarming motility, which was linked to the ability to
elaborate flagellins on the bacterial surface under different conditions.
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NOMENCLATURE
ABACUS Array based analysis of cistrons under selection
ABC ATP-binding cassette transporter
AmpR Ampicillin resistance
ATCC American type culture collection
CFU Colony forming units
CmR Chloramphenicol resistance
DFI Differential fluorescence induction
DMEM Dulbecco’s modified eagle medium
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
DOC Deoxycholate
FACS Fluorescence activated cell sorting
FAE Follicle associated epithelium
FBS Fetal bovine serum
FLP Flippase recombination enzyme
FRT Flippase recognition target
FUN Genes of unknown function
GALT Gut associated lymphoid tissue
GFP Green fluorescent protein
GSP General secretory pathway
ix
IVET In vivo expression technology
IVI In vivo induced
KanR Kanamycin resistance
LB Luria Bertani medium
LD50 Lethal dose at which 50% death occurs
LPS Lipopolysaccharide
NalR Nalidixic acid resistance
NRAMP Natural resistance associated macrophage protein
OD Optical density
P22 Phage used for transduction of Salmonella
PAGE Polyacrylamide gel electrophoresis
PAMP Pathogen associated molecular pattern
PBS Phosphate buffered saline
PBST Phosphate buffered saline with 0.5% TWEEN (polysorbate)
PCR Polymerase chain reaction
PVDF Polyvinylidene fluoride membrane
RIVET Recombinase based in vivo expression technology
RNA Ribonucleic acid
ROS Reactive oxygen species
SCOTS Selective capture of transcribed sequences
SCV Salmonella containing vacuole
SDS Sodium dodecyl sulfate
xSEC Translocase of the general secretory pathway
SPI Salmonella pathogenicity island
SSC Saline sodium citrate buffer
STM Signature tagged mutagenesis
STM# Salmonella serovar Typhimurium gene number
Tat Twin arginine translocation
TATFIND Twin arginine signal prediction software
TatP Twin arginine signal prediction software
TCA Tri-chloroacetic acid
TdT Terminal transferase enzyme
TMDH Transposon mediated differential hyridization
TraSH Transposon site hybridization
TTSS Type three secretion system
XP 5-bromo-4-chloro-3-indolyl-b-D-phosphate
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1CHAPTER I
INTRODUCTION TO SALMONELLA
Background
Salmonella are responsible for millions of cases of food-borne illness and
millions of cases of Typhoid Fever worldwide, despite efforts to reduce transmission of
these organisms [1]. The majority of cases of salmonellosis in the United States are the
result of food-borne infection with broad host range serotypes Typhimurium and
Enteriditis [2,3,4]. One factor that has impacted the ability to control infection and
transmission of this organism is that Salmonella are able to survive in numerous niches,
including in diverse animal hosts, on vegetables and fruits, in the environment for
livestock or vegetable production (farm, water, soil, etc.), and in other locations during
food production.
Salmonella was first isolated in 1885 by Salmon and Smith as the bacterium
thought to be responsible for hog cholera (later shown to be caused by a virus).
Currently there are two species recognized: Salmonella enterica and Salmonella
bongori. Salmonella enterica is divided into 6 subspecies containing over 2000
serotypes (Figure 1).  Salmonella serotypes are differentiated and classified based on
outer membrane structures LPS (O antigen), flagella (H antigen) and capsule (Vi
antigen).
____________
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2[5,6]. Additional methods, such as phage typing, allow more detailed differentiation of
Salmonella within a particular serotype. Approximately 1454 serotypes belong to
subspecies I, a group of isolates that is responsible for 99% of mammalian and avian
infections. Other subspecies are naturally found in reptiles and are commensals in this
niche, but can be transmitted to and occasionally cause disease in mammals.
Figure 1 : Organization of the Genus Salmonellae.  The Genus Salmonellae is
organized into 2 species, Salmonella enterica and Salmonella bongori. Subspecies I of S.
enterica is responsible for 99% of mammalian infections.
 Organization of the Genus Salmonellae
2 Species:
1. Salmonella enterica
      (2463 serot.)
   subspecies:
I. Enterica
II. Salamae
IIIa.Arizonae
IIIb. Diarizonae
IV. Houtenae
VI. Indica
2.  Salmonella bongori (Cold blooded Vertebrates., formerly ssp. V)
 1454 serotypes
Typhimurium
Enteritidis
Newport
Typhi/ Paratyphi
Choleraesuis
Dublin
Pullorum
Gallinarum
‘broad host’
‘narrow host’
Cold blooded 
vertebrates
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3Salmonella are capable of causing two distinct diseases depending upon the
infecting serotype and the nature of the host. Typhoidal serotypes, such as Salmonella
enterica serotypes Typhi and Paratyphi, lead to a systemic enteric fever, but are limited
to the infection of humans. Non-typhoidal serotypes, on the other hand, cause
gastroenteritis or enterocolitis in a broad range of warm-blooded hosts. The most
common non-typhoidal serotypes isolated from humans are Typhimurium and
Enteriditis. The ability of certain serotypes to infect a broad range of hosts, while other
serotypes are host limited may be attributed to the differences in genetic make-up of
each strain, however, this is only a small percentage of the genome.
Animal Models of Infection
Salmonella enterica serotype Typhimurium can be used to study both typhoidal
and non-typhoidal disease. Infection with serotype Typhimurium leads to murine
typhoid in susceptible mice (BALB/c, C57B/6), that carry a non-resistant allele of the
NRAMP (natural resistance- associated macrophage protein)[7,8,9] gene.  These
susceptible mice succumb to typhoid symptoms within 5 days of oral infection, thus they
are a model for systemic disease in immunocompromised individuals, such as those with
HIV, as well as Human Typhoid Fever. Mice that carry a wild type NRAMP gene
(129sV, CBA, A/J) are not susceptible to systemic infection and are used to study long-
term persistence of Salmonella because they colonize the intestine in high numbers
[10,11].
4Calves are a natural host of serotype Typhimurium and their use as a model
system has real implications for food safety, as well as understanding human disease,
due to the similarities in the pathogenesis and progression of the disease[12,13,14].
Orally infected calves develop similar clinical symptoms, including diarrhea
[12,13,15,16], and intestinal pathology [17,18]. In a diarrheal model of infection,
ligation of the ileal loops is used to observe changes in fluid accumulation, comparing
the pro-inflammatory response of calves infected with wild type versus mutant strains
[19,20,21,22]. Other relevant livestock models of infection include swine, chickens and
rabbits.
Pathogenesis
Salmonella enterica serovar Typhimurium is a zoonotic bacterium that causes
gastroenteritis in healthy individuals, but can lead to systemic disease in
immunocompromised individuals. The onset of symptoms of gastroenteritis occur within
12-72 hours after ingestion of contaminated food or water (Figure 2); clinical symptoms
include diarrhea, abdominal cramps, nausea and vomiting lasting 4-7 days in otherwise
healthy individuals. Resolution of symptoms typically occurs without the use of
antibiotics and it has been shown that use of antibiotics actually prolongs symptoms, as
well as the period of asymptomatic shedding that follows. Complications such as
septicemia and Reiter’s syndrome (arthritis) are rare [23]. In individuals with a
depressed immune system, infection with Salmonella can lead to a chronic infection and
even death. The effects on the immunodeficient is of special importance in developing
5countries with a high incidence of HIV, which is often correlated with a high incidence
of non-typhoidal Salmonella infection.
Figure 2: Salmonella Pathogenesis. Orally ingested Salmonella passes through the
stomach and the upper intestine before invading the epithelium of the small intestine.
Once the epithelial layer is breached, Salmonella may be disseminated though the
reticuloendothelial system. Adapted from Haraga et al. [24].
6Salmonella must survive in many niches of the host during infection. First, the
Acid Tolerance Response is induced to protect against low pH in the stomach, but in
addition, global regulation by rpoS induces cross-protection against many other
environmental conditions [25].  The bacteria move down the intestinal tract, where they
invade the intestinal epithelium, the Gut Associated Lymphoid Tissue (GALT) [26],
using the SPI-1 (Salmonella Pathogenicity Island) type-three secretion system (TTSS).
There are 13 annotated fimbrial operons [27]that potentially aid in attachment to
epithelial cells; fim encodes a Type I fimbriae [28,29], agf encodes curli fimbriae
[30,31], and there is little information about lpf, pef, bcf, stb, stc, std, stf, sth, sti, saf, and
stj. Recently, lpf, bcf, stb, stc, std, and sth were shown to be involved in intestinal
persistence in a mouse model of infection [32].
Salmonella are able to heavily colonize the Peyer’s patches [33]. Invasion of M-
cells, specialized lymphoid cells on Peyer’s patches, and intestinal epithelial cells is
regulated by hilA [34,35] and the SPI-1 TTSS [36]. SPI-1 effectors SopB, SopE and
SopE2 trigger cytoskeletal rearrangements that are necessary for invasion [37,38]. SopB
induces macropinosome formation and fission of the Salmonella Containing Vacuole
(SCV), thus affecting trafficking within the cell [39,40].
SPI-1 invasion mediates inflammation and fluid accumulation in the infected
intestine [13,41,42,43,44,45,46]. The release of chemokines, including IL8 and CXC
chemokines from epithelial cells is promoted by the TTSS-1 effectors SipA, SopA,
SopB, SopE1 and SopE2 [47]. Once inside the cell, Salmonella is contained inside the
SCV. Inside this compartment, secretion of effectors from the TTSS-2 is induced. The
7effectors of the TTSS-2 modulate the fate of the SCV, leading to inhibition of lysosomal
fusion [48,49,50] and altered vacuolar trafficking [49,50,51], including inefficient
trafficking of vesicles containing oxidative compounds [51,52]. Salmonella escape into
the lamina propria, either passing through epithelial cells, slipping between cells via
disrupted tight junctions or by sampling of dendritic cells. Once the Salmonella have
breached the boundary of the epithelium, they are phagocytosed by macrophages. The
SPI-1 effector sipB has been shown in vitro to bind Caspase-1 of the resident
macrophages and induce apoptosis [53,54]. Caspase-1 also induces IL1B and IL18,
leading to a pro-inflammatory response, benefiting the bacteria by affecting the normal
intestinal flora [55]. Proinflammatory signaling results in a large influx of
polymorphonuclear neutrophils (PMNs) leads to fluid secretion, likely by producing
prostaglandins that affect Na+/Cl- channels of the host cells [56].  The result is damage
to the intestinal epithelium and diarrhea.
SPI-2 TTSS is essential for intracellular growth [57,58,59] within macrophages,
a process necessary for systemic infection [60]. Inside the macrophage, the bacteria
reside within a specialized structure called the Salmonella Containing Vacuole (SCV).
SPI-2 secretes effectors including SpiC that inhibit normal trafficking of endocytic
vesicles, as well as inhibition of phagolyosomal fusion, seen in cultured J774
macrophages [49].
SPI-2 also inhibits localization of reactive nitrogen species (RNS) and vesicles
containg NADPH-oxidase, which leads to the production of reactive oxygen species
(ROS) [51,61].  ROS act to inhibit growth of Salmonellae early during infection [62],
8and vesicles containing ROS are localized to the SCV through TNFα receptor p55
signaling  [61]. RNS controls the growth of Salmonellae during both early and late
phases of infection, in contrast to ROS [62,63,64]. Antimicrobial peptides have also
been shown to be important for controlling growth of Salmonella within macrophages
[65].
Growth rates of Salmonellae during infection are increased in susceptible models
of infection [10,66]. A single amino acid substitution in Slc11a1/Nramp is associated
with susceptibility to systemic infection in mice and leads to altered function of a
divalent metal ion pump of the macrophage late endosome [8,9]. The macrophage is
only able to slow growth of the organism, and eventually, the bacteria are able to escape
the macrophage through the production of necrotic cytotoxins [67,68,69].
Toll-like receptors of the macrophages are able to recognize pathogen associated
molecular patterns (PAMPs)  such as LPS, flagella, and bacterial DNA. TLR4, which
recognizes Lipid A of LPS, has been shown by in vivo and in vitro methods to be
required by the host during innate immune response due to Salmonella infection
[70,71,72,73]. TLR2 was shown to work with TLR4 to promote TNFα production [74]
and LPS induced shock is mediated by waaN mutation in Salmonella [75]. Also, curli
amyloid fibrils, produced by the csg operon, have been shown to up-regulate Nos2
expression in a TLR-2 dependent manner, likely contributing to sepsis [76].
T and B cells are necessary for clearance, antigen specific immunity, and
prevention of relapse or chronic carrier state of salmonellosis. CD4+ TCRαβ+ T cells are
necessary for late stages of infection for control of growth, as observed in
9immunodeficient mice infected with a ΔaroA strain of Salmonella [77]. Systemic
infection with Salmonella leads to activation of CD4+ cells (CD44high and CD62Llow) and
a Th1 skewed phenotype, increasing the efficiency of the cellular immune response [78].
B cells are necessary for Th1 development [79,80,81]. B cells generally produce
antibodies, but are also capable of presenting antigen to T cells upon infection with
pathogens, including Salmonella [82,83]. Salmonella can inhibit T cell proliferation by
direct contact inhibition in a SPI-1 and SPI-2 independent manner [84], as well as
inhibiting MHCII in a sifA dependent process [85].  Genes involved in these mechanisms
may be of special interest since inhibition of T cells blocks clearance and leads to a
chronic carrier state, also known as long-term persistence.
Once the clinical symptoms of Salmonella gastroenteritis subside, an
asymptomatic carrier state begins. Typhimurium can be shed in the feces of the infected
individual for an average of 8 weeks [86]. Infected livestock may shed from six months
to the life of the animal. Long- term asymptomatic shedding is a serious problem in the
food chain because detection of these passive carriers is difficult. Infected livestock can
shed 105 CFU/gram in their feces and remain asymptomatic.  According to the USDA
Hazard Analysis and Critical Control Points (HACCP), meat products are randomly
sampled during production, but there are no methods to prevent contamination at
slaughter and during pre-production and there is no microbial testing of carcasses for
infection. Identification of novel genes involved in systemic infections, intestinal
persistence and long term shedding, and the development of new methods to reduce
subclinical and chronic carriage is of paramount importance to food safety.
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Identification of Novel Virulence Factors
Salmonella have acquired a vast array of mechanisms that allow them to adapt
and thrive in a variety of conditions. In the current genomic era, forward genetics,
genomic sequencing and many technologies developed in the wake of complete genome
sequencing are revolutionizing the identification of genes required for Salmonella
survival in many environments. Identification of Salmonella genes necessary for growth
in different niches has made rapid progress in recent years, as the molecular biologic
tools for their identification become more sophisticated and are applied to study this
organism in an increasing number of environments. In the following chapter I detail the
identification of Salmonella genes required in niches that have been studied to date, and
describe advances in forward genetic and functional genomic approaches that are
advancing this important area of study.
Genomic Sequencing
Understanding the Salmonella biology comprehensively begins with sequencing.
Recent reductions in the cost, along with improvements in sequencing technology have
made it possible to rapidly sequence many Salmonella genomes. The current status of
genome sequencing of non-typhoidal Salmonellae has recently been reviewed [87], and
since the beginning of 2009 two additional genomes have been completed, and a number
of sequences have been updated (Table 1).
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Table 1: Sequencing Progress of Salmonella Isolates.
Sequences completed SequencingCenter
GenBank
Accession # Citation
Arizonae 62:z4,z23 WU CP000880.1
Agona SL483 JCVI CP001138.1
Cholerasuis SC-B67 Taiwan AE017220.1 Chiu et al. (2005) NAR33:1690-1698 [88]
Dublin CT_02021853 TIGR CP001144.1
Enteriditis P125109 (PT4) Sanger AM933172.1 Thomson et al. (2008) GenomeRes. 18:1624-1637 [89]
Gallinarum 287/91 Sanger AM933173.1 Thomson et al. (2008) GenomeRes. 18:1624-1637 [89]
Hadar Sanger
Heidelberg SL476 JCVI CP001120.1
Infantis Sanger
Newport SL254 TIGR/JCVI CP001113.1
Paratyphi A ATCC 9150 WU CP000026.1 McClelland et al. (2004) NatGenet 36:1268-1274 [90]
Paratyphi A AKU_12601 Sanger AM412236 Holt et al. (2009) BMCGenomics 10:36-47 [91]
Paratyphi B SPB7 SGSC4150 WU CP000886.1
Paratyphi C RKS4594, SARB49 Peking University CP000857.1
Salmonella bongori 12149 Sanger
Schwarzengrund CVM19633 TIGR CP001127.1
Typhi AG3/Vietnam 1998 Sanger NZ_CAAY00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi CT18/Vietnam 1993 Sanger AL513382.1 Parkhill et al. (2001) Nature413:848-852 [92]
Typhi Ty2 Russia 1916 UWisconsin/Sanger AE014613.1
Deng et al. (2003) J
Bacteriology 185:2330-2337
[93]
Typhimurium DT104 Sanger
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Table 1 Continued
Sequences completed SequencingCenter
GenBank
Accession # Citation
Typhimurium LT2 WU AE006468.1 McClelland et al. (2001)Nature 413:852-856 [27]
Typhimurium SL1344 Sanger
Sequences under
assembly
Sequencing
Center
GenBank
Accession # Citation
4,[5], 12:I: CVM23701 TIGR/JCVI NZ_ABAO00000000
Hadar RI_05P066 TIGR/JCVI NZ_ABFG01000000
Heidelberg SL486 TIGR/JCVI NZ_ABEL01000000
Javiana GA_MM04042433 JCVI NZ_ABEH02000000
Kentucky CDC 191 JCVI NZ_ABEI01000000
Kentucky CVM29188 TIGR NZ_ABAK02000000
Newport SL317 JCVI NZ_ABEW01000000
Saintpaul SARA23 TIGR NZ_ABAM02000000
Saintpaul SARA29 TIGR NZ_ABAN01000000
Schwarzengrund SL480 JCVI NZ_ABEJ01000000
Tennessee CDC07-0191 CDC NZ_ACBF00000000
Typhi E98-0664/Kenya 1998i Sanger NZ_CAAU00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi 150(98)S/Vietnam 2004 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi 404ty/Indonesia 1983 Sanger NZ_CAAQ00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi 8(04)N/Vietnam 2004 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E00-7866/Morocco 2000 Sanger NZ_CAAR00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
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Table 1 Continued
Sequences under
assembly
Sequencing
Center
GenBank
Accession # Citation
Typhi E01-6750/Senegal 2001 Sanger NZ_CAAS00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E02-1180/India 2002 Sanger NZ_CAAT00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E02-2759/India 2002 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E03-4983/Indonesia 2003 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E03-9804/Nepal 2003 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E98-2068/Bangladesh 1998 Sanger NZ_CAAV00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi E98-3139/Mexico 1998 Sanger NZ_CAAZ00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi ISP-03-07467/Morocco 2003 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi ISP-04-06979/Africa 2004 Sanger Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi J185SM/Indonesia 1985 Sanger NZ_CAAW00000000 Holt et al. (2008) Nat Genet40:987-993 [91]
Typhi M223/Unknown 1939 Sanger AE014613.1 Holt et al. (2008) Nat Genet40:987-993 [91]
Virchow SL491 TIGR/JCVI NZ_ABFH02000000
Weltevreden HI_N05-537 TIGR/JCVI NZ_ABFF01000000
Sequences in progress SequencingCenter
GenBank
Accession # Citation
Arizonae 05-0715 ATCC BAA-1577 WU
Diarizonae 61:1,v:1,5 WU
Diarizonae ATCC BAA-1579 05-
0625 48:i:z WU
Houtenae SARC13 ATCC BAA-
1580 45:a:e,n,x WU
Houtenae SARC14 ATCC BAA-
1581 11:b:e,n,x WU
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Table 1 Continued
Sequences in progress SequencingCenter
GenBank
Accession # Citation
Indica ATCC BAA-1576 WU
Indica ATCC BAA-1578 WU
Salamae ATCC BAA-1582 (05-
0626) 47:b:1,5 WU
Salamae SARC3 58:d:z6 WU
Abortusovis SSM0041 WU
Bovismorbificans 01-05481 PT13 WU
Braenderup S-500 WU
Brandenburg KMR12 Korea
Dublin U Illinois
Enteriditis 48-0811 WU
Enteriditis LK5 U Illinois
Enteriditis P125109 Korea
Enteriditis SARB17 WU
Enteriditis SARB19 WU
Indiana KMR53 Korea
Infantis SARB27 WU
Miami ATCC BAA-1586 (02-3341) WU
Montevideo SARB30 WU
Muenchen SARB32 WU
Muenchen SARB34 WU
Muenster ATCC BAA-1575 (0065-
00) WU
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Table 1 Continued
Sequences in progress SequencingCenter
GenBank
Accession # Citation
Newport CVM36720 UMIGS
Panama KMR64 Korea
Paratyphi B ATCC BAA-1585 WU
Paratyphi B SARB47 WU
Paratyphi B tartrate (+) [Java] ATCC
BAA-1584 (S-1241) WU
Poona SGSC4934 WU
Pullorum U Illinois
Schwarzengrund KMR78 Korea
Sendai 55-2461 WU
Senftenberg SARB59 WU
Stanley SARB60 WU
Thompson SARB62 WU
Typhi SGSC2661 WU
Typhi Ty21a Naval MedResearch Center
Typhimurium 14028s WU
Typhimurium D23580 Sanger
Typhimurium DT2 Sanger
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The data compiled from sequencing projects has allowed the development of
microarrays, and comparative genomic, transcriptomic, and forward genetic studies
using these tools [27,94,95,96,97,98].  Microarray technology has also recently been
described as a novel method for the rapid molecular typing of Salmonella isolates [99].
Annotated genomes are the foundation for functional genomic studies, yet even
annotation cannot completely describe a genome. The first complete Salmonella genome
sequences were published in 2002, but gaps in our knowledge of these genomes persist.
Annotation only assigns a putative function to genes based on sequence homology to
genes of known function, and this is only a starting point for determination of the
function of a gene. For example, the annotated genome of Salmonella enterica serotype
Typhimurium LT2 contains three genes that are annotated as citE (STM0060, STM0622,
and STM3120), and are assigned the function of a citrate lyase by homology (Figure 3).
However, whether the proteins encoded by these genes really have an identical function
or not, and the timing, conditions of the expression of these three genes and the
importance of each of these genes in growth and survival, will only be determined by
functional studies. Furthermore, in the Typhimurium LT2 sequence, there are
approximately 1000 genes out of 4500 that have been assigned as putative, in terms of
location in the cell, but have no assigned function. The case for other genomes is similar,
for example, Typhi has approximately 200 hypothetical and 600 conserved hypothetical
open reading frames [92]. In the future, it will be vital to our understanding of virulence
mechanisms and pathogenesis, to assign well-characterized functions to all genes within
the genomes of interest.
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Figure 3: Context of Multiple Citrate Lyase Homologs within the Salmonella
Genome. A) Region surrounding STM0060 (citE2) B) Region surrounding STM0622
(citE) and C) Region surrounding STM3120 (Adapted from Goulding et al. [100]).
Genetic content, along with what is known about the niche preferences of
different serotypes, may also provide information about the ability to survive within
different hosts or environments. Comparison of the LT2 sequence with sequences of
closely related serovars, such as Typhi, Enteriditis, Galinarum, Cholerasuis, and Dublin
has revealed interesting differences between serovars that infect a broad range of hosts
and those that are more specialized and infect only specific hosts. Host specialist
genomes, such as Typhi and Cholerasuis, typically contain a large number of
pseudogenes: Typhi has approximately 200 [92] and Cholerasuis has 151 [88], while the
host generalist Typhimurium has only 39 [27]. Typhimurium also has a large array of
fimbrial operons, encoding up to 13, presumed to be necessary for survival within
different hosts [27]. More specialized strains, such as Dublin [97] and Typhi [92],
encode a much smaller repertoire of fimbria. In contrast, Salmonella Pathogenicity
Islands appear to be rather stable across serovars, leading some to believe that the
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differences that do exist are necessary for host adaptation, while the machinery (i.e. type
three secretion systems) remains intact.
In order to identify genes important in particular niches, two broad approaches
have been employed. Promoter-trapping strategies and microarray-based approaches
(Table 2) have been used to evaluate gene expression under particular sets of conditions.
Such studies offer both a limited set of genes to explore for functional importance during
a particular process, as well as a more comprehensive determination of gene expression
changes that can be used to outline and analyze pathways necessary for a particular
process. Forward genetic screens, and now functional genomics are being used to
identify genes required for survival and growth of Salmonella, in particular niches. The
generation of mutants using various methods, and the study of these mutants in various
environments remains a definitive method for identifying necessary genes and beginning
a molecular determination of their function in the environment under study.
Salmonella Genetic Screens: A Review
In Vivo Expression Screens: IVET
Promoter trap strategies were first developed in the 1980s [101] and they enabled
the identification of promoters that are up-regulated in particular environments,
including infected tissue. In vivo expression technology (IVET) was originally described
in 1993 as a method for identifying genes specifically induced during Salmonella
infection (in vivo induced genes, or ivi) [102]. In general this strategy works in the
following way; a library of fragments of genomic DNA from the genome of interest is
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cloned upstream of a gene necessary for growth under a particular condition and
integrated into the Salmonella genome. This promoter trap library is then screened for
reporter expression during infection, and constitutive promoters are excluded by
comparison of in vitro expression with expression during infection. In the initial IVET
screen, Typhimurium genomic DNA was cloned upstream of a promoterless purA-lacZY
fusion, in a purA mutant background, and fusions were placed in single copy on the
bacterial chromosome [102]. BALB/c mice were infected with a pool of these promoter
trap chromosomal fusions and three days post-infection, bacteria were recovered from
infected spleens [102]. Surviving bacteria had PurA expression during infection [102].
Constitutive promoters were excluded by testing the recovered strains for in vitro
expression of lacZY on MacConkey lactose inhibitor plates. In this initial screen, genes
necessary for de novo pyrimidine synthesis (carAB) and LPS synthesis (rfb) were shown
to be expressed during infection of murine models, and requirement of the genes during
infection was confirmed by determination of LD50 of Salmonella mutants in these genes
[102].
The next generation of IVET was developed to broaden applicability to other
host/pathogen systems and uses an antibiotic resistance reporter, cat, instead of purA
[103]. After infection with a pool of chromosomal fusions, mice are supplemented with
chloramphenicol to select for expression of the resistance marker during infection. Using
this method, a gene required for fatty acid degradation, fadB, was identified and
expression of the promoter fusion was confirmed in the presence of oleate [103].
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This strategy was also used to identify Salmonella genes induced in RAW 264.7
macrophages [103]. Five ivi fusions were identified and individually tested for growth in
macrophages in the presence of chloramphenicol. The strains, MT735-MT739, showed a
500-1000 fold increase in growth in macrophages supplemented with chloramphenicol
compared with random “non-selected” fusions [103]. While these specific fusions were
not characterized further, ivi fusions necessary for growth in macrophages found in later
studies were shown to be PhoPQ regulated and/or iron responsive [104,105].
The two versions of IVET described above were also used to identify Salmonella
promoters induced during infection of BALB/c mice by the oral and intraperitoneal
routes, as well as during infection of RAW 264.7 macrophages [104]. Three different
infection models were chosen to identify novel genes expressed during infection, and for
internal validation. Genes required for global gene regulation (phoP, pmrB, cadC,
iviXIII, and vacBC), during stationary phase (spvB, cfa, otsA), for metabolism (recD,
hemA, entF, fhuA, cirA, mgtAB, iviX and ndk), and genes required for adhesion and
invasion (iviVI-A and iviVI-B) were identified as induced during infection in this large-
scale screen [104]. Three genes of unknown function were also identified and
determined to be important for survival within macrophages, iviXI, iviXII, and iviXV
[104]. Identification of fusions in 2 or more infection routes, such as the spleen after
intraperitoneal infection and during macrophage infection, were used as internal controls
and validation for the study. In a follow-up study, ivi fusions (mgtAB, spvB, iviVI-A,
iviXVI, phoP, pmrB, iviXVII, fhuA, cirA, and entF) were tested for responsiveness to low
pH and low Mg2+, conditions that may exist within the Salmonella containing vacuole
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[105]. Each of these genes may not individually be responsible for full virulence of
Salmonella and the authors cite the inv locus of Yersinia, which shows no defect in LD50
studies, but is important for invasion of cultured epithelial cells and colonization of
Peyer’s patches [106]. Heithoff therefore argues that the summation of the “in vivo
induction profile” is necessary for the ability of Salmonella to survive and replicate in a
variety of niches, despite a lack of forward genetics.
IVET in animal models provides general information about promoters that are
induced during infection, yet it does not provide any information regarding the specific
location where these promoters are induced. In order to determine spatial induction of
promoters, it is necessary to break the animal model down and examine specific organs
that may be important during infection, such as the liver. IVET was used to identify
promoters that are induced during infection of cultured murine hepatocytes [107]. Genes
identified in this screen included known virulence factors sodA, pagJ and ssaE, as well
as an iron transport operon, sitABCD [107]. The sit operon is located on Salmonella
Pathogenicity Island 1 (SPI-1) and was shown to be required for full virulence in
BALB/c and C3H/HeN mice infected by the oral an intraperitoneal routes of infection,
but it is not required for initial invasion of Henle 407 epithelial cells or hepatocytes
[107].
In Vivo Expression Screens: RIVET
IVET has been further modified using a highly sensitive recombinase method
called Recombinase- based IVET (RIVET) [108]. A library of promoter fusions is
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generated upstream of a promoterless resolvase, tnpR, that induces excision of an
antibiotic resistance cassette when it is expressed. A loss of tetracycline resistance is a
permanent marker of induction that occurred at some point during the infection, enabling
the identification of transient events. RIVET was initially used the screen for promoters
expressed in Vibrio cholera during infection of infant mice.
In Salmonella enterica serotype Typhimurium, RIVET was recently used to
identify promoters expressed during infection in swine [109]. Genomic DNA was cloned
upstream of a promoterless Cre-LacZ cassette and the resulting library of plasmids was
transformed into a strain harboring a chromosomal cassette containing a gene for sucrose
sensitivity (sacB) and kanamycin resistance flanked by loxP sites. When the upstream
genetic element is activated, the Cre recombinase is expressed and both the sacB and the
kanamycin resistance genes are excised, resulting in sucrose resistance and kanamycin
sensitivity. In conjunction with a modified signature tagged mutagenesis strategy
(described later in this chapter), this method was used to identify 32 unique promoters
that are induced during infection in swine [109]. Huang et al. also found expression of
regions that were cloned in a reverse orientation and suggest that they may have
identified anti-sense regulators [109]. The recombinase plasmid used in this study also
encodes a promoterless lacZ reporter downstream of Cre, which was used to measure the
level of induction of certain promoters, using a β-galactosidase assay, under specific
environmental conditions, such as high temperature and osmotic stress [109].
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In Vivo Expression Screens: DFI
Differential Fluorescence Induction (DFI) is an alternative promoter trap strategy
that utilizes GFP as a reporter along with fluorescence-activated cell sorting (FACS)
analysis to find promoters that are active during infection, independent of antibiotic
susceptibility or metabolic requirements [110,111,112]. A library of Salmonella genomic
DNA fragments is cloned upstream of promoterless GFP and expression of GFP can be
examined under a variety of conditions. Initially, DFI was used to identify promoters
induced upon exposure to an acidic environment, such as Salmonella might experience
in the stomach, or within macrophages and in intracellular vacuoles [110]. Promoters
that were induced upon exposure to low pH, but repressed when exposed to high pH
were termed acid inducible genes and included the promoter for cyclopropane fatty acyl
phospholipid synthase (cfa) [110]. Induction of cfa is necessary for modification of the
Salmonella membrane in response to stress [113].  DFI was subsequently used to
examine promoters induced when Salmonella was associated with host cells, such as
RAW 264.7 macrophages [111]. Among the genes induced within macrophages were
PhoPQ regulated and OmpR/EnvZ regulated genes, as well as members of Salmonella
Pathogenicity Island 2 (SPI-2), encoding the type three secretion system 2 (TTSS-2)
[111].
Host cell auto-fluorescence, which can make it difficult to distinguish GFP
expressing bacteria from host tissue, is a major drawback to using GFP as a reporter.
This limitation has been reduced using two-color flow cytometry [112]. Three promoters
expressed during infection have been identified during oral infection of BALB/c mice
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using this two-color flow cytometry DFI method [112]. AroQ is one of many chorismate
mutase genes encoded in the Salmonella genome, and is necessary for biosynthesis of
aromatic amino acids. Pathogenicity Island encoded protein B (pipB), which lies
upstream of sopB (SPI-1 effector protein) on SPI-5, has been shown to be necessary for
virulence in BALB/c mice infected orally [114] and subsequently shown to be secreted
by the SPI-2 TTSS [115]. Another SPI-2 effector, sifA, was also identified in this screen
and is required for virulence in mice associated with formation of filamentous structures
of the Salmonella containing vacuole [116].
This flow cytometry approach has also been used to identify Salmonella
promoters that are up-regulated in tumors in mice, a tissue for which Salmonella has a
specific tropism [117]. Nude mice were infected with a library of 180,000 promoter-trap
fusions to otherwise promoterless GFP, and clones were recovered from tumors and
normal spleen tissues and sorted by FACS for GFP expression. Clones expressing GFP
in vitro were sorted out, and the remaining clones were subjected to additional rounds of
enrichment for tumor specific promoters. Promoters of genes required under hypoxic
conditions, including pflE (pyruvate-formate-lyase actvating enzyme), flhB (flagellar
apparatus) and ansB (asparaginase) were identified in this study as specifically induced
in tumor tissue [117]. The identification of tumor specific promoters will be useful for
targeting chemotherapeutic agents to be expressed specifically in tumors.
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In Vivo Expression Screens: Transcriptional Profiling by Microarray
Transcriptional profiling by microarray is another high-throughput method to
determine genes that have altered expression under a specific set of conditions. This
method can be used in all phases of the Salmonella life cycle and has been used to
analyze global transcript changes in regulatory mutants, gene regulation during
infection, and during in vitro growth under infection relevant conditions, such as bile
(see review [118]). Identification of Salmonella genes expressed during infection
presents a unique set of challenges, however. Most importantly, bacterial RNA must be
separated from the host RNA in order to determine only those bacterial genes that are
differentially regulated. In 2003, Eriksson et al. described a novel method of bacterial
RNA isolation from infected macrophages that involved the use of detergent to
specifically lyse the eukaryotic cells and a phenol-ethanol mixture to stabilize the RNA
[119]. High quality bacterial RNA was used to obtain a global transcriptional profile of
bacterial genes, by probing a whole genome microarray bacterial RNA collected from
Salmonella infected J774 macrophages at 4, 8, and 12 hours post-infection. Such work
has shown that one quarter of the Typhimurium genome (919 genes) displayed altered
expression at 4 hours post-infection of macrophages [119]. Salmonella Pathogenicity
islands, along with other genes necessary for survival within the Salmonella containing
vacuole (SCV) were up regulated, while many gene products expressed on the bacterial
surface including LPS, fimbria and flagellar genes were down regulated. Nearly half of
the genes with altered expression when Typhimurium is inside macrophages are of
unknown (FUN genes). FUN genes are also defined as genes with putative functions
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based on homology to other organisms, but with no biological evidence for
confirmation. In this study two regions, STM0854-0859 and STM3117-3120, were
identified as expressed in macrophages and also having structural features of
pathogenicity islands, [119].
Transcriptional profiles of Typhimurium have also been determined in cultured
epithelial cells at various time points after infection, and this data can be compared to
earlier work in macrophages [120]. HeLa cells were infected with Typhimurium and
RNA was isolated at 4, 8 and 12 hours. While a large proportion of genes show a similar
pattern of expression in both cell-types, including 128 genes of unknown function,
differences in the transcriptome signatures between the different cell types also have
several significant differences.
TTSS and flagellar expression during infection of the two cell types are
prominent features that differ during Salmonella infection of macrophages versus
epithelial cells. In epithelial cells, SPI-1, encoding TTSS-1 necessary for invasion of
normally non-phagocytic cells, was expressed throughout the infection. But in
macrophages, a phagocytic cell type, the need for TTSS-1 appears to be less critical as
SPI-1 transcription was down regulated in this cell type [120]. While SPI-2 genes
(encoding the TTSS-2) were expressed in both cell types, SPI-2 encoded genes appear to
be more highly transcribed in macrophages than in epithelial cells [120]. During
infection of macrophages, SPI-2 transcripts were highly elevated at all time points, while
in epithelial cells, transcript levels were reduced over the 12 hour course of infection
[120].  In contrast, flagellar genes were up-regulated at later time points during infection,
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which may signal the need for motility at this stage is a necessary bacterial adaptation to
prepare for lysis from dying epithelial cells [120].
In Vivo Expression Screens: SCOTS
An alternative method for preferentially isolating bacterial RNA from infected
eukaryotic cells, termed selective capture of transcribed sequences or SCOTS, is a
subtractive hybridization method [121]. In this method, Salmonella genomic DNA is
prepared and biotinylated for use as a probe. Eukaryotic cells are infected with
Salmonella, and at a pre-determined time point post-infection, total RNA is isolated and
cDNA is prepared. cDNA from infected cells that hybridizes to the biotinylated
Salmonella genomic DNA is isolated using streptavidin, specifically enriching for the
bacterial sequences transcribed during infection.
Transcriptional differences between broad host and host-adapted Salmonellae
(Typhimurium versus Typhi), have been examined using SCOTS.  These studies
identified a fimbrial operon (stfACDEFG) and a LysR type regulator stmR (STM3121),
which are present in Typhimurium, but are not found in Typhi and may be necessary for
survival in a wider range of hosts [121]. The stf operon was also shown by a PCR based
subtractive hybridization method to be absent in Typhi [122].
Recent studies using SCOTS have identified genes expressed in macrophages
and have utilized microarray technology in order to bring this technology to higher-
throughput. Typhi genes that were expressed during infection of human monocytes
(THP-1 cells) at 0, 2, 8 and 24 hours post-infection were identified using this
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combination of methods [123]. The expression of approximately 117 genes, including
genes of unknown function, was elevated at all intracellular time points [123]. The
TTSSs were up-regulated early in infection. SPI-1 expression fell off shortly after
infection, while SPI-2 expression remained high throughout the infection. Genes
encoding proteins involved in antimicrobial peptide resistance were expressed at high
levels early and late, but many were repressed at 8 hours. Genes involved in motility and
iron transport were repressed throughout Typhi infection of macrophages.
Differences were observed between this study of host specific serotype Typhi in
THP-1 human monocytes and the results of earlier studies examining gene expression of
broad-host serotype Typhimurium in murine are perhaps a result of the host specificity
of the serovar that was studied. Specifically, phoP, slyA and antimicrobial resistance
genes displayed differential regulation when comparing transcriptional profiling of
Typhimurium and the SCOTS profile of Typhi [123], consistent with the different niches
that each serotype is exposed to during infection. Such comparative analysis may yield
further clues to the evolutionary basis of host preference.
In vivo expression and expression profiling have been heavily used in animal
models and in cultured cells to provide lists of genes that may be critical during
infection, or growth in a particular environment. Limitations do exist however, as these
methods may not be able to detect transient events that occur during infection and may
give the impression that genes are not heavily differentially regulated in a given
environment are dispensable in that niche. Thus, gene expression studies are best used as
a platform for determining groups of genes that are coordinately regulated, in an effort to
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build an overview of the network of gene expression, and as a tool to determine and
prioritize candidate genes for further genetic studies.
Comparative Genome Analysis
The genus Salmonellae is genetically diverse and contains over 2000 different
serotypes. In the pre-genomic era, examinations of this genetic diversity among isolates
were done using simple genomic DNA hybridization methods described previously. In
the current genomic era, genome comparison includes the use of high-throughput
technologies, such as sequencing and microarrays. Use of these methods has allowed
genomic comparison between Salmonellae in greater depth. Genetic differences between
closely related strains have led to a new designation, genovars, and widespread use of
the genovar designation will hopefully reduce the inaccuracies of the current serotyping
classification system of Salmonellae [124]. By comparing the genomes of broad host
range serotypes with narrow host range serotypes, it has also been possible to identify
genes that are potentially responsible for the ability of Salmonella to invade certain hosts
[96,98].
Forward Genetic Screens
Large-scale genomic studies yield a broad overview of important aspects within
the genomes of a variety of serovars, but they also create a platform for more focused
studies using classical techniques, such as forward genetics. The power of forward
genetics lies in the ability to examine the function of a gene by disrupting that gene and
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looking for a change in phenotype. For decades, researchers had only tools that would
enable mutagenesis in the absence of sequence data, such as chemical mutagens and
radiation treatment. More recently, re-engineered, stable transposable elements have
been used to create banks of mutants for phenotypic analysis
[60,125,126,127,128,129,130,131,132,133,134,135,136]. Screening these mutants,
however, continued to be tedious due to limitations on studying many mutants
simultaneously, and because sequencing of candidate mutants one at a time was
necessary to determine the location of transposons. The development of several negative
selection techniques improved the throughput and allowed screening for mutants that
were not viable during infection. The publication of the first genome sequences for
Salmonella [27,92], and the development of microarrays, allowed high-throughput
screening methods for both transposon mutants and targeted deletions.
Signature Tagged Mutagenesis: The Development
 In 1995 Hensel et al. described the first negative selection strategy used during
infection with Salmonella, called signature tagged mutagenesis (STM). STM combined
transposon mutagenesis and tracking of each individual transposon mutant using short,
exogenously introduced, unique sequence tags on the transposons themselves [137].
These unique tags, or barcodes, were used to identify each mutant when mutants were
pooled for infection, using Southern blotting for these unique tags. Small pools of
mutants were assembled and subjected to a genetic selection during intraperitoneal
infection of BALB/c mice, an established model for Typhoid fever [137]. Mutants
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differentially represented in the input pool versus the output pool recovered from the
murine spleen after infection were identified using Southern analysis [137].
Approximately 40 mutants were identified as present in the output with reduced
frequency in this study, and these mutants included those in a region that was later
termed Salmonella Pathogenicity Island 2 (SPI-2), encoding a type three secretion
system (TTSS-2) [138].
The development of STM was not only a technical advance in the methods
available to study bacterial pathogens during infection, it was also a large advance in our
understanding of the biology of complex organisms. Numerous STM studies in
Salmonella have followed, building upon the important work of the initial study, by
determining genetic requirements for infection in numerous niches and for different
serotypes of Salmonella.
Signature Tagged Mutagenesis: Comparative Studies Across Species
STM has been used for comparative studies; specifically for comparing the
genetic requirements for Salmonella survival and growth during infection of different
host species. In order to compare the Salmonella genes that were required in mice versus
calves, a small pool of 260 serotype Typhimurium mutants was used for comparison
during oral infection of these two different host species. Salmonella genes required
during infection of these two hosts were classified in three categories, those necessary in
mice but not calves, those necessary in calves, and those necessary in both hosts.
Surprisingly, the largest category of Salmonella mutants that were identified in this study
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were necessary for survival in both mice and calves [139], providing a basis for future
work that initially identifies Salmonella gene requirements in mice and later tests these
in more cumbersome and expensive livestock models. Four mutants (slrP/STN39,
bcf/STN35, yaiO/STN08, and STN28) were identified as important for virulence in only
one host species; three genes were determined to be necessary in mice and one gene was
required only in calves. One mutant, identified as defective for colonization in mice, but
not calves, was further characterized. The defective gene in this mouse-colonization
deficient mutant, in a Salmonella leucine-rich protein slrP, has significant homology to
ipaH and yopM, secreted effectors of type three secretion systems in Shigella and
Yersinia, respectively [139]. STM has also been employed to comparatively study
genetic requirements for Typhimurium infection in the natural hosts calves and chicks,
using a much larger number of transposon mutants than were previously studied
[139,140]. In these studies, calves and chicks were infected with pools of signature
tagged mutants to identify genes necessary for virulence in either or both host systems
[140].  SPI-4 was identified as an important determinant of virulence with a specific role
in cattle. SPI-4 is a 27 kb region encoding a type I secretion system and a very large non-
fimbrial adhesin protein, siiE [140,141,142,143,144]. The siiABCDEF operon is
regulated by sirA, hilA and rfaH [145,146,147], and mutants in siiE are attenuated for
virulence in mice and cattle [140,143,144]. SPI-4 is also co-regulated with SPI-1 and
required for apical invasion of polarized epithelial cells, destruction of tight junctions,
cytoskeletal rearrangement and effacement of the brush border [146,148]. The large size
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of siiE is a requirement for its function, as it must reach past the lipopolysaccharide of
the cell to interact with the host cell [148].
Candidate genes necessary for virulence in swine have also been identified using
STM [149].  Genes in pathogenicity islands SPI-1 through 6 were identified as candidate
mutants that were under-represented after infection in swine. Mutants in Salmonella
atypical fimbria (saf) genes after infection of swine suggest a role for this adhesin during
infection, and a subtle role for saf was confirmed in a competitive oral infection of
swine. Mutants in a structural component of SPI-1, prgH, were also defective in
colonization of cattle and pigs [140,149], and the efficacy of the prgH mutant as a
vaccine candidate has been explored [149]. Finally, over 40 genes encoding proteins of
unknown or hypothetical function were identified after STM screening in swine,
including STM0557 (gtrC1), a gene that has since been characterized as  necessary for
O12 antigen form variation and persistence of Typhimurium in the murine intestine
[150]. STM has also been used to identify serotype Typhimurium genes in an ex vivo
assay, with swine stomach contents as the selective mechanism [151]. Several genes of
putative function were identified from the 34 pools of 48 mutants tested, as defective in
the ability to survive the harsh, acidic environment of the stomach.
STM has also been used to determine genes necessary for host-specific serotype
Cholerasuis to survive in swine. A pool of 45 Cholerasuis mutants was used to infect
pigs orally and intraperitoneally, in order to identify genes necessary for both routes of
infection by this host specific serotype [152]. Mutants in the regulatory gene hilA
(hyper-invasive locus A)were attenuated in oral, but not inteperitoneal infections in
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swine [152], as observed for Typhimurium in cattle and mice [36,139,153]. STM
mutants of serotype Cholerasuis have also been delivered to swine using an intranasal
route of infection. Two genes required for virulence, STM1459 (putative oxidoreductase
protein) and STM2626 (Gifsy-1 prophage replication protein) were identified in this
study [154].
Gene requirements for survival of the host specific Salmonella serotype Dublin
in calves have also been studied using STM methodology. 5000 Salmonella serotype
Dublin STM mutants were studied during infection of calves and BALB/c mice to
determine genes necessary for virulence in each host [155]. Mutants defective for
virulence in one host, but not the other were rarely observed compared to mutants
defective in both hosts, similar to results seen in previous studies of Typhimurium in two
hosts [139,155]. In serot. Dublin, mutants in ssaT, encoding a component of the SPI-2
TTSS apparatus, were defective in both host models [155]. A second TTSS-2 mutant in
sseD, encoding a SPI-2 secreted effector, was initially identified in this STM screen as
specifically defective for virulence in mice. However, when examined in a single
systemic infections, the sseD mutant was defective in both mice and calves [155]. These
data indicate that sseD mutants may be transcomplemented by other Salmonella mutants
during the calf infection, but not during the murine infection. The sseD mutant was
further characterized in oral and ileal infections in the calf that are used to study enteric,
rather than systemic disease. Consistent with previous conclusions that SPI-2 is not
required for invasion of the intestinal epithelium, the sseD mutant and the wild type were
recovered equally from ileal loop infection, while SPI-1 mutants was recovered at lower
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levels [155]. During oral infection of calves however, sseD mutants were decreased
significantly 2 days post-infection in feces compared to the wild type [155]. While the
oral and ileal data initially seem disconnected, they are consistent with the hypothesis
that Salmonella reseed the intestinal lumen from the mucosa, where SPI-2 is required for
proliferation.
A defined, small-scale method was used by Pullinger et al. in 2007 [156]. Thirty-
six mutations previously generated and characterized in Typhimurium were  generated in
serotype Dublin using the lambda red recombinase methods [140] [156,157]. These
defined mutants were used to infect cattle orally and identify genes necessary for
translocation from the gut to the mesenteric lymph node.  This study showed that the
SPI-4 T1SS is necessary for persistence and translocation from enteric to systemic sites
while the TTSS-2 is not required for this translocation.
Improvements to Signature Tagged Mutagenesis: TraSH
As investigators have continued to use STM heavily, improvements have been
made to the original technology. Alternate methods have been developed to use PCR to
assay changes in representation of members of the pool [158], in studies using mutant
pools with reduced complexity. Using this strategy, the requirement for serotype
Gallinarum genes for growth and survival of this host specific serotype in chicks was
determined after oral infection [159]. Mutants in genes encoded in SPI-10 (sefD) and
SPI-13 (STM3118-3120) were defective during this host specific infection [159].
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The use of unique sequence tags embedded within the transposon was
revolutionary, but certain drawbacks limited the further applications of STM technology.
Transposon-based mutagenesis and pool sizes limited to the number of available
sequence tags, 96 or fewer, constrained the use of STM for comprehensive functional
genomic studies. For large-scale genome-wide screening, two groups simultaneously
developed methods to use microarray technology and the idea of signature tagging
without exogenously added tags to study bacterial pathogens [160,161]. Each group
designed transposons bearing outwardly facing T7 promoters that could promote in vitro
transcription from genomic DNA flanking each insertion site, generating a unique
transcript for each mutant. The representation of these transcripts in a pool was
evaluated by using ORF microarrays [160,161]. This strategy was named Transposon
Site Hybridization or TraSH [161], and made the use of additional exogenous sequence
tags unnecessary. Although this method was developed for use in Mycobacteria, a
similar approach was also used in E. coli [160] and was subsequently adapted for use in
Salmonella.
TRASH screening was used to follow 50,000 pooled transposon mutants in
serotype Typhimurium during intraperitoneal infection of BALB/c mice of short
duration, as well as infection of cultured RAW 264.7 macrophages [162]. Many of the
genes identified in this study, including those in genes of SPI-2, were previously
identified as important in this murine model by Hensel et al. using STM. These data
verified that this T7 based method worked in Salmonella. However surprisingly, in these
studies genes encoded on SPI-1 were shown to play a role in replication and survival in
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macrophages, and sirA was identified as a potential regulator of SPI-1 function within
macrophages [162]. Finally, the vast majority of genes required for virulence in these
experiments exist only in Salmonellae [162],  suggesting that Salmonella-specific genes
are an important category of genes for further study [94].
The genetic requirements for Typhimurium persistence in systemic sites has also
been studied using this T7-microarray based method in Salmonella- resistant mouse
models [163]. Salmonella resistant mice were infected for up to 28 days, in order to
investigate genetic requirements systemic persistence [163]. Infected animals were
sacrificed and the mutant pools were analyzed at 7, 14, 21 and 28 days post-infection,
allowing specific identification of genes necessary for long-term intestinal persistence.
Similar to short term systemic colonization, studies of long-term colonization of
systemic sites also identified a large complement of Salmonella specific genes as
necessary including genes of SPI-2. Genes required for restructuring the bacterial outer
membrane, including the rfa and rfb clusters, also appear to be necessary for long term
colonization of systemic sites by serotype Typhimurium [163]. Finally, mutants in SPI-1
effectors were underrepresented within 7 days post infection. The effectors SipCBD
appear to be necessary not only for establishment of infection, but also for more long
term role that is poorly understood [163].
Improvements to Signature Tagged Mutagenesis: TMDH
Until recently, pools of transposon mutants have been evaluated using primarily
ORF microarrays. Because this type of microarray contains open reading frames,
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transposon insertions in non-coding regions, or very small coding regions that can’t be
amplified by PCR, are not assayed. A new quantitative method termed Transposon
Mediated Differential Hybridization (TMDH), that uses a novel high-density tiling array
containing 60-mer oligonucleotides spaced every 100 base pairs along both strands of
the genome alleviates these issues [164]. The transposons developed for generating
mutants in this method, Tn5 and Mu, have an outward facing T7 promoter on one end
and an outward facing SP6 promoter on the opposite end. Representation of transposon
mutants in the pool was evaluated by hybridizing labeled transcripts to the tiling array.
Use of this array allows determination of the location of each transposon insertion with
much higher resolution than is possible with other types of arrays.
 Approximately 10,000 serotype Typhimurium Tn mutants were studied, pooled
in groups of 480 or 384 and used to infect mice intravenously. Comparison of the
representation of individual mutants in pools used to infect mice (input pools) to the
pools recovered from mice (output pools) were evaluated, however, the input and output
are not directly compared to each other on the same slide. A second minor limitation is
that multiple transposons located very near each other in the same region cannot be
distinguished from each other, a factor that limits the pool size that can be tested. Using
the TDMH method Chauduri et al. identified the position of 8,533 transposon mutations,
with 6,108 transposons unambiguously mapped to 2,824 genes, roughly half of the
Salmonella genome. A large data set of “unbiased relative fitness” was generated from
this study, and 47 genes were targeted for deletion and studied further using single
infections in BALB/c mice. Mutants in trxA, atpA, and tolA were further tested in
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immunization and protection studies, and found to provide protection against i.v.
challenge (trxA and atpA) or against i.v. and oral challenge (tolA) .
Problems with Transposon Mutagenesis
Transposon mutagenesis is a valuable tool for genetic studies, but its use is
limited in particular environments where members are lost at random from pools of
mutants, as sometimes occurs during infection. In order to generate a mutation in each
gene in the Salmonella genome using random mutagenesis approaches, transposon
libraries must be highly complex. Generally 5-10 times more transposon mutants are
generated than there are genes in the genome of interest in order to have a high
probability of generating a mutation in each gene in the genome. During genetic
selections where many mutants are lost at random (also termed a “bottleneck”), it is
difficult to accurately evaluate representation of individual mutants in such complex
pools. This is one factor that necessitates the use of smaller pools of Tn mutants, such as
in STM and in TMDH approaches used for Salmonella, during infection. Pool sizes that
do not fluctuate at random must be determined empirically for each route of infection
and niche to be studied. Use of small pool sizes also does not allow comprehensive
screening of the genome in non-traditional animal models, such as livestock, where it is
prohibitively expensive to use many animals for screening. Additional drawbacks of
transposon-based mutagenesis include random location of the insertions themselves, and
potential polar effects on downstream genetic elements.
40
Targeted Deletion Libraries
The rapid availability of complete genome sequence information, combined with
straightforward techniques for generating targeted mutants in enterobacteriacae, allow
the development libraries of targeted deletion mutants, thus generating one mutant in
each gene in the genome. Reduction in the number of mutants, thus reducing the
complexity when mutants are screened as a pool, is a major advantage of the generation
of targeted mutants. Targeted deletion libraries that contain mutants in each non-
essential gene have been developed in S. cerevisae, Cryptococcus neoformans [165] and
E. coli (the Keio collection [166]). The following chapters detail work on the
development of a similar library in Salmonella enterica serotype Typhimurium and a
novel array based screen used to identify mutants defective during systemic infection.
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CHAPTER II
ARRAY BASED ANALYSIS OF CISTRONS UNDER SELECTION
Introduction
Genetic screening remains one of the most efficient methods to identify genes
associated with a phenotype of interest in bacteria. Array-based methods for these
screens originated with the transposon-based “signature tagged mutagenesis” (STM)
strategy that used unique signature sequences in each transposon to evaluate the relative
abundance of individual mutants in pools after selection [167]. STM was later improved
by modifying the mutagenizing transposon to include a T7 RNA polymerase promoter
(PT7) that is used to generate a unique transcript for each mutant from the genomic
sequence adjacent the mutation. This modification makes exogenous unique sequence
tags unnecessary. Relative abundance of the input and output PT7 transcripts is monitored
using an ORF microarray [160,161,163,168].
Transposon mutagenesis suffers from several drawbacks. First, tens of thousands
of random transposon insertion mutants are necessary to ensure that mutations occur in
most small genes; mathematical simulations indicate that 40,000 random mutants would
still fail to disrupt over 200 of the 1,100 annotated open reading frames in Salmonella
that are less than 500 bases in length. Second, this need for a high complexity is a critical
limitation for genetic screens in environments, including live animals, where the
bacterial population may fall to low levels during infection. These ‘bottlenecks’ may
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occur at various points during infection – for example, survival of the acidic
environment in the stomach, invasion of Peyer’s patches and survival in the bloodstream
represent some of the processes where the founder population may be very small. Such
‘bottlenecks’ cause undesirable random loss of mutants and complicate forward genetic
screening in such environments. In addition, the polar nature of transposon insertions
makes mapping of a phenotype more difficult.
We used the lambda-red recombination method that includes features to
minimize polarity [157] to construct targeted deletion mutants in Salmonella. We added
a PT 7 to the cassette inserted during mutagenesis, positioned to produce a gene-specific
transcript from the genomic sequence adjacent to the insertion. Thus, our targeted
deletion mutants can be pooled for genetic screens. Far fewer specific mutants are
needed to ensure representation of every gene of interest than is needed when using
random transposon mutagenesis. We introduce a novel and inexpensive array designed
for monitoring changes in specific deletion mutant representation in the pool after
selection. Finally, we demonstrate the utility of these techniques by identifying novel
candidate mutations in genes encoding proteins and sRNAs that appear to affect the
fitness of mutants in competitive infection with wild-type Salmonella, and we validate
eleven of these fitness phenotypes.
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Results
Genome Sequencing
The virulent Salmonella enterica serovar Typhimurium ATCC14028 is
extensively studied both in vitro and in vivo. To design primers for generation of our
deletion collection, we produced a near complete draft sequence of this genome using
the 454 shotgun approach (GenBank accession in process). The ATCC14028 sequence
was compared to the completed genome of the 1,000-fold less pathogenic laboratory
strain Typhimurium LT2 [169]. As expected, over 95% of the two genomes were
orthologous, and the orthologous regions had less than 1% divergence. The ATCC14028
and LT2 genomes differ only by a few hundred single base mutations (including a
mutation in rpoS that is partly responsible for the attenuation of LT2 [170]), the absence
of the two Fels phage in ATCC14028, and other insertions and deletions encompassing
less than 40 kb (McClelland et al., unpublished data).
Generation of Specific Gene Deletions in ATCC14028
We targeted 1,052 genes for deletion [171], primarily genes in Salmonella that
are not found in E. coli [169]. Such genes are usually in very A+T rich regions [172],
and include nearly all of the ~200 genes previously associated with Salmonella
virulence, including the Type III secretion systems (TTSS) and their known effectors.
Targeted deletions were also generated in nearly all of the 100 genes in fimbrial and
surface antigen regulons. Finally, we deleted a subset of genes shared by Salmonella and
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E. coli, including 44 known and candidate sRNAs, and genes that have known motility,
regulatory and pathogenesis functions.
The original vectors for the lambda-red swap strategy, pKD3 (CmR) and pKD4
(KanR) [157], were redesigned to include a T7 RNA polymerase promoter positioned to
generate a unique transcript from the Salmonella genome directly downstream of each
mutant. The construct includes an ATG and ribosome binding site (RBS) to preserve any
translation coupling. An outline of our variation on the red-swap strategy is in Figure 4.
The sequences of the redesigned vectors, pCLF3 and pCLF4, are available in GenBank
(Accession numbers EU629213 and EU629214, respectively).
We designed 65mers that contain the same 3’ sequence of 20 bases for vector
PCR that were used previously [157], but with a 45-base rather than the conventional 35-
base gene-specific portion, to allow a secondary function for the oligonucleotides as
probes in a microarray (described later). Homology of the oligonucleotides with the
genome was positioned so that each swap eliminated the entire gene except for the
coding regions of 30 base pairs at the 5’ and 3’ ends of each gene. These two ends of
each gene were preserved to minimize unintended effects on adjacent genes caused by
removal of the gene sequence and insertion of the mutagenic cassette.
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Figure 4:Generation of Specific Deletions in S. enterica serovar Typhimurium
ATCC14028. Our procedure is identical to the Red-swap described in Datsenko and
Wanner [157] with the exception that we re-engineered the original insert to include an
in-frame T7 RNA polymerase promoter (PT7), and the sequences used for recombination
are longer. A gene, identified in the schematic as genE, is targeted for deletion. Two
65mer primers (red) are used to amplify the region containing the antibiotic resistance
cassette, the PT7, and the FRT (Flippase recognition target) sites (among other elements)
from the plasmid pCLF4. The resulting PCR product has 45 base sequences at each end
that are homologous to sequences near the 5’ and 3’ ends of the targeted ORF.
Transformation of these PCR products into ATCC14028 expressing lambda Red
recombinase in trans leads to a recombination event, resulting in the swap-in of the PCR
product, and the swap-out of the targeted gene. A ribosomal binding site (RBS) and a
downstream ATG start codon near the 3’ end of the inserted sequence ensures that a 12
amino acid peptide is made from any RNA that is transcribed in this strand to reduce
polar effects. Targeted mutants in many genes were pooled and used for Array-based
analysis of cistrons under selection (ABACUS).
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If FLP recombination is used to remove the antibiotic cassette after mutant
construction then an open reading frame is generated including ten codons from the 5’
end of the original gene, 39 amino acids from the lambda-red mutagenesis referred to as
a “scar” Figure 5 , and nine amino acids and the stop codon from the original gene. In
our constructs, the T7 promoter remains in place in the scar after FLP recombination.
We also increased the level of throughput in the generation of our mutant
collections. Lambda-red swap recombination in ATCC14028 was performed with a
mixture of two PCR products, one originating from pCLF4 containing a kanamycin
resistance cassette (KanR, sense orientation) and one originating from pCLF3 containing
a chloramphenicol resistance cassette (CmR, antisense orientation). Each transformation
was plated on LB-Kan and LB-Cm, and two transformants from each plate were colony
purified and stored (a total of four transformants). These two collections marked with
different antibiotic resistance cassettes facilitate the construction of double mutants by
transduction.
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Figure 5: Anatomy of the “Scar” Left by the Antibiotic Resistance Cassette.
Antibiotic resistance markers in targeted genes can be removed using FLP recombinase,
resulting in a gene encoding a mini-protein of the first ten amino acids of GenE, 39
amino acids from the inserted DNA (called a “scar”), and the last nine amino acids of
GenE, and retaining the PT7.
The Salmonella genes targeted for deletion were spot-checked by PCR. Of 1,052
mutants attempted, 1,040 produced KanR or CmR clones, or both [171]. To confirm that
mutations occurred at the targeted location, two clones obtained for the first 304 KanR
mutants and for 231 CmR mutants were checked by PCR using primers to the flanking
genomic regions. Only one mutation was incorrect.
The accuracy of FLP recombination to remove the antibiotic resistance marker
was verified for twelve transformants (as detailed in the Methods and Materials section).
FRT
ΔgenE::FRT
PT 7
Scar includes 10aa on C- and N-terminus of genE
    ATG XXX XXX XXX XXX XXX XXX XXX XXX XXX
 V   Q   A   G   A   A   S   K   F   L   Y   F   L   E   N   R   N   F
GTG CAG GCT GGA GCT GCT TCG AAG TTC CTA TAC TTT CTA GAG AAT AGG AAC TTC
 G   I   G   I   P   K   L   I   R   L   T   I   G   R   P   K   E   D
GGA ATA GGA ATT CCG AAA TTA ATA CGA CTC ACT ATA GGG AGA CCT AAG GAG GAT
 I   H   M
ATT CAT ATG XXX XXX XXX XXX XXX XXX XXX XXX XXX stop
RBSPT 7
FRT
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The mutant including flanking regions was amplified by PCR, and both strands of the
amplification product were sequenced. All twelve swaps examined were precise, and
each recombination event resulted in the intended truncated open reading frame.
Array-based Verification of PT7 Location and Activity from a Pool of Mutants
We used a NimbleGen tiling array to verify the correct insertion and activity of
the PT7 in all of our mutants simultaneously. 1,031 KanR mutants were pooled by
growing each mutant separately to stationary phase in LB, mixing in equal volume, and
storing as glycerol stocks at -80ºC. The region 3’ to each mutation in the pool of 1,031
KanR mutants was labeled by a novel method designed to generate uniform signals from
every PT7 (Materials & Methods and Figure 6). For the necessary DNA fragmentation
prior to amplification and labeling, we replaced the restriction digestion step used in
previous protocols with genome shearing and polyA tailing. To identify active PT7 in the
mutants, labeled RNA obtained by T7 in vitro transcription from the pool was
hybridized to a custom NimbleGen tiling array of 50mer oligonucleotides covering the
ATCC14028 genome in overlapping 24 base steps on both strands. Oligos directly
adjacent to each functional insert and in the opposite strand from the transcript
hybridized intensely, with a rapid decrease in signal over a 200 base region [171]Using
this method we simultaneously identified 933 inserts from KanR mutants with functional
PT7 sites in the correct location. 48 additional KanR mutants are likely correct but could
not be formally confirmed, due to an overlapping transcript from a nearby mutation in
another mutant in the pool. 50 KanR mutants (4.8% of all pooled mutants) did not
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Figure 6: Labeling Technique for Detection of Mutants in a Pool by Array
Hybridization.
in vitro T7 transcription: direct
incorporation of Cy5/Cy3-UTP
5’ AAAAAAAAAAAA 3’
Labeled RNA
Hybridization to an array
Primer 1
Inserted cassette
5’
Growth of pool of mutants
under selective conditions
Preparation of DNA
Shearing by sonication
Terminal transferase:
addition of poly-dA to 3’ ends
TTTTTTTTTTTTT 5’
AAAAAAAAAAAA 3’
PT7
TTTTTTTTTTTTT 5’
AAAAAAAAAAAA 3’
PT7
PT7
Primer 2
Two sequential PCRs primed
with oligo-dT and nested,
insert-specific primers
VNT24CC 5’
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display active transcription at the correct location perhaps due to a mutation in the PT7.
Four inserts were at an incorrect location.
We repeated these experiments with a pool of 972 CmR mutants and at least 892
of these have a functional PT7. 78 CmR mutants were in genes where a KanR clone was
not confirmed. Overall, KanR or CmR mutants, or both, were confirmed in 1,023 genes
out of 1052 targeted for deletion. We have not studied the CmR clones further, but these
mutants should be useful as a pool and also for the construction of double mutants in
combination with KanR clones.
Failure to generate the correct targeted mutation could occur if the mutation was
lethal. We did not attempt to delete any genes that are orthologous to genes previously
reported to be essential in E. coli [166]. However, we did target 38 genes that were
previously reported as essential in Salmonella [173] and succeeded in obtaining mutants
in all but two; STM1008, a phage gene that has a close paralogue in the genome, and
seems unlikely to be essential in LB, and STM2087, encoding an enzyme required for
the synthesis of LPS side chains.  It is likely that very few of the 29 failures to construct
a mutant were due to lethality of the mutant.
Generation and Testing of an ‘In house’ Microarray for Screening
Pools of our mutants can be studied using competitive assays and the
representation of each mutant can be determined using microarrays. For such detection,
we manufactured an economical “in house” array based on 1,241 65mers derived from
the 3’ ends of genes, including all those previously utilized for mutant construction.
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Oligonucleotides of 45 bases in length produce a more robust RNA hybridization signal
[174] than the 35mers that are normally used for lambda-red recombination [157].  As
negative controls we included in the array 308 65mer oligos with homology to the 3’ end
of mutants that had not yet been generated and were therefore absent from the pool, and
955 65mers designed on the 5’ end of genes (previously used for mutant construction).
One aliquot of the pool of 1,031 KanR mutants was used to test the “in house”
array. Labeled RNA probe was prepared from the pool, and hybridized to the array as
described (Materials and Methods). A specific 27 base oligonucleotide, complementary
to the conserved 27 bases of RNA produced from the inserted region common to every
mutant, was included in the hybridization. This 27mer blocks cross-hybridization of this
portion of the T7 transcripts to a complementary 20 base sequence present in each of the
3’ gene probes (Figure 7). Specific signal at least three-fold over the mean signal of the
negative controls was detected for 97% (905) of the 933 mutants known to be in the
pool. Only seven (0.7%) of the 5’ oligos included as negative controls in the array
hybridized, possibly due to a transcript from a nearby mutant in the complementary
strand.
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Figure 7: Addition of the 27mer Competitor Oligo Results in High Specificity of
Array Detection.
Genes That Affect Fitness of Salmonella During Passage Through BALB/c Mice
BALB/c mice develop fatal systemic infection from S. enterica serotype
Typhimurium, as can also occur in humans infected with S. enterica serotype Typhi. We
used intraperitoneal infection in BALB/c mice, a well-studied model
[126,129,136,137,162], to demonstrate that our mutant screening method could correctly
identify both previously observed and novel gene requirements during infection. A
group of six BALB/c mice were infected intraperitoneally (IP) and bacteria were
recovered from the spleen after euthanasia at 48 hours post-infection. Labeled RNA
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probe was prepared using aliquots of DNA from the input pool and output pools from
each animal as outlined in Figure 6, and the labeling protocol was repeated with dyes
reversed. Hybridizations were performed using twelve slides, each slide containing the
array printed in triplicate. The data were processed using WebArray [175], as described
in Materials & Methods, and are summarized in Figure 8.
Figure 8: Loss of Defined Mutants From the Input Pool After Intraperitoneal
Delivery to Six BALB/c Mice and Recovery From Spleen at 48h Post-Infection.
Twelve array hybridizations were performed using two each for six mice. WebArray
analysis results using quantile normalization for all oligos representing candidate
deletions in the pool are shown. Data with P<0.0005 are depicted in red, those with
P>0.0005 in grey. The X-axis plots the data for each of the mutants in the order in which
those mutants occur in the Salmonella genome. Mutants confirmed individually in a
competitive assay with wild-type are labeled in blue. Examples of important genetic
elements are marked in black.
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At a threshold of a two-fold change and P<0.0005, 120 mutants showed a change
in fitness in IP infection. Among the most unfit were mutants in the TTSS encoded by
SPI-2, and associated effector genes, and genes for cell wall biosynthetic enzymes, all
known to be important during systemic infection [137,162]. We identified 51 mutants
that have previously been identified during intraperitoneal screens as defective (Table
2).
Table 2: Mutants without Previously Known Phenotypes. We identified 51 mutants
not previously identified during infection and grouped them into functional categories.
Unknown function Regulator Enzymatic function
STM0081 STM1547 (putatitive marR family) STM0719
STM0731 STM2639 (rseA, anti sE) STM0857
STM1600 STM3121 (stmR) STM1151 (mdoH)
STM1760 (TPR repeat) STM3687 (mtlR) STM3120 (citE)
STM1948 STM4417 STM3119 (maoC, ripB homolog)
STM2303 (pmrM, pbgE3) STM0693 (Fur, transcript repressor) STM3339 (nanA)
STM2329 STM3846 (putative RT)
STM3047 (ygfY) STM4475 (valS, valine tRNA synthase)
STM3089 (yqgD) STM4489 (putative helicase)
STM3155
STM3783 
STM4504
STM4529
STM4599 (yjjY)
c-di-GMP Porin/transport PhoP/Q related
STM0551 STM1131 STM1544 (pqaA, phoQ reg)
STM1344 (cdgR/ydiV) STM3975 (tatC) STM1601 (ugtL)
STM1697 STM1258 (ABC trans)
STM2215 (rtn) STM3763 (mgtB), Mg Transport LPS
STM2672 (yfiN) STM2120 (asmA)
Flagellar biosynthesis Scavenger Kinase
STM1971 (fliH) STM2777 (iroN) STM1670
STM2116 (wzc)
Small RNAs
leuX
sroA
sraA 
istR
rybB
oxyS (FOR)
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Fifteen mutants without previously known fitness phenotypes during systemic
infection in this model were selected from among the 120 statistically top-ranked
candidate mutants. These included mutants in all five candidate sRNA, a supernumerary
tRNA (LeuX), and nine randomly picked from among the protein coding genes. These
15 mutants were studied one at a time in competitive assays with wild-type
ATCC14028, after P22 transduction of each mutation to a clean genetic background.
The phenotypes observed in the pool of mutants were confirmed for eleven mutants, as
listed in Figure 9 and Table 3. To reduce the chance of polar effects on nearby genes,
the KanR cassette was removed by FLP recombination from all eleven mutants with
confirmed competitive index phenotypes and eight of these (STM1131, STM2303,
STM3120, STM3121, sroA, istR, leuX, and oxyS) were retested in competitive infections
in BALB/c mice (Figure 9). The phenotype was confirmed in all eight of these
unmarked mutants that should have minimal or no polar effects. Four mutants failed to
reiterate the phenotype observed in the mutant pool (sraA, rybB, STM4529, and
STM0857) but this result does not rule out confirmation of a phenotype in a study
involving more animals.
57
Figure 9: Competitive Index Experiments with Individual Mutants Versus Wild
Type After Intraperitoneal Delivery and Recovery from the Spleen, Liver, and
Cecum. 106 cfu of 933 mutants (pool) or a 1:1 mixture of individual mutants versus
wild type ATCC14028 ΔphoN::KanR were injected into 5-6 mice and recovered from the
spleen one or two days post infection. Statistical significance was determined using a
Student’s 2-tailed t-test, and asterisks indicate that normalized output ratios were
significantly statistically different from the equivalent ratio in the inoculum. **P-value
of <0.001, *P-value of <0.05. Strains marked with a (FRT) have undergone FLP-
mediated recombination to reduce or eliminate polar effects. None of the mutants have a
change in fitness during growth of the pool in LB for four serial passages to stationary
phase with 100-fold dilutions (data not presented). Confirmation of mutants, identified
by ABACUS, in competitive infections in BALB/c mice. ABACUS prediction for
selected mutants (black bars) and confirmation data from competitive infections in
BALB/c mice (dark blue bars are from spleen, lighter blue bars are from liver and
cecum) of infected animals.
Log Ratio Pool Spleen
CI Spleen
CI Liver
CI Cecum
-4
-2
-1
0
1
∆ l
eu
X
(F
R
T)
∆ 2
30
3
∆ 2
30
3(
FR
T)
∆2
21
5
∆ s
ro
A
∆s
ro
A
(F
R
T)
∆ 1
76
0
∆ 3
12
0
∆3
12
0(
FR
T)
∆2
12
0
∆3
12
1
∆ 3
12
1(
FR
T)
∆ i
st
R
∆ i
st
R
(F
R
T)
∆1
13
1
 ∆
11
31
(F
R
T)
∆ o
xy
S
∆ o
xy
S
(F
R
T)
∆l
eu
X
*
*
* *
*
*
*
*
*
**
**
*
**
****
****
** **** ** **** ** ****
*** ** **
** ***
** *
** *****
**
** ****
** ****
** ****
Lo
g 1
0 (
C
FU
 m
ut
an
t/C
FU
 W
T)
58
Table 3: Competitive Infection Data. Bold denotes statistical significance, *death after
24 hours, but prior to 48 hours post-infection.
Gene Mutant Locus
ABACUS (pool
of 933 mutants)
Competition with wt
(single mutant)
  
 
ratio
spleen /
input p-value CI
standard
error p-value
STM0731 ΔSTM0731::kan Spleen 0.18 2.E-04    
Spleen*   0.68 0.06 5.E-04
Liver*   0.55 0.07 7.E-02STM0732 1ΔSTM0732::kan
Cecum*   0.74 0.1 7.E-03
Spleen 0.47 8.E-03 1.28 0.03 2.E-03
Liver   1.37 0.04 1.E-02STM0857 ΔSTM0857::kan
Cecum   1.08 0.02 7.E-03
Spleen* 0.44 1.E-04 0.0008 0.78 2.E-02
Liver*   0.002 0.25 5.E-042ΔSTM1131::kan
Cecum*   0.007 0.78 6.E-02
Spleen   0.37 0.06 2.E-04
LIver   0.58 0.07 3.E-03
STM1131
ΔSTM1131::FRT
Cecum   0.32 0.4 2.E-01
Spleen* 0.19 1.E-06 0.35 0.17 4.E-02
Liver*   0.59 0.22 3.E-01STM1760 ΔSTM1760::kan
Cecum*   0.46 0.24 2.E-01
Spleen 0.22 9.E-12 0.09 0.06 1.E-04
Liver   0.07 0.08 2.E-04STM2120 ΔSTM2120::kan
Cecum   0.04 0.25 6.E-03
Spleen* 0.12 2.E-08 0.01 0.14 1.E-04
Liver*   0.01 0.14 1.E-04STM2215 ΔSTM2215::kan
Cecum*   0.02 0.22 1.E-03
Spleen 0.08 6.E-12 0.12 0.08 3.E-04
Liver   0.27 0.14 2.E-02ΔSTM2303::kan
Cecum   0.2 0.16 2.E-02
Spleen   0.22 0.09 1.E-03
Liver   0.32 0.24 9.E-02ΔSTM2303::FRT
Cecum   1.42 0.22 5.E-01
Spleen   0.23 0.04 1.E-04
Liver   0.4 0.09 1.E-02
ΔSTM2303::FRT
pWSK29
Cecum   0.52 0.08 2.E-02
Spleen   1.51 0.04 3.E-02
Liver   2.18 0.04 2.E-03
STM2303
ΔSTM2303::FRT
pWSK29::STM2303
Cecum   4.76 0.14 8.E-03
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Table 3 Continued
Gene Mutant Locus
ABACUS (pool
of 933 mutants)
Competition with wt
(single mutant)
  
 
ratio
spleen /
input p-value CI
standard
error p-value
Spleen* 0.15 5.E-08 1.22 0.04 5.E-01
Liver*   1.31 0.05 3.E-01STM2639 ΔSTM2639::kan
Cecum*   1.2 0.25 9.E-01
Spleen* 0.19 1.E-06 0.13 0.15 1.E-02
Liver*   0.28 0.04 9.E-04ΔSTM3120::kan
Cecum*   0.35 0.09 2.E-02
Spleen   0.22 0.04 <1.E-7
Liver   0.17 0.1 7.E-04
STM3120
ΔSTM3120::FRT
Cecum   0.06 0.25 6.E-03
Spleen 0.38 1.E-05 0.31 0.11 4.E-03
Liver   0.28 0.06 2.E-04ΔSTM3121::kan
Cecum   0.27 0.26 9.E-02
Spleen   0.07 0.07 8.E-06
Liver   0.08 0.05 2.E-06ΔSTM3121::FRT
Cecum   0.03 0.1 2.E-05
Spleen   0.14 0.08 1.E-04
Liver   0.22 0.19 1.E-02
ΔSTM3121::FRT
pWSK29
Cecum   0.25 0.32 9.E-02
Spleen   3.75 0.09 1.E-02
Liver   4.83 0.15 3.E-02
STM3121
ΔSTM3121::FRT
pWSK29::STM3121
Cecum   5.32 0.33 2.E-01
Spleen 0.05 6.E-12 0.0001 0.14 <1.E-7
Liver   0.0002 0.14 <1.E-7ΔleuX::kan
Cecum      
Spleen   0.01 0.12 <1.E-7
Liver   0.01 0.16 <1.E-7
leuX
ΔleuX::FRT
Cecum   0.05 0.29 6.E-03
Spleen 0.41 5.E-06 0.34 0.12 3.E-02
Liver   0.24 0.22 7.E-02ΔistR::kan
Cecum      
Spleen   0.42 0.09 1.E-02
Liver   0.41 0.09 1.E-02
istR
ΔistR::FRT
Cecum   0.03 0.4 2.E-02
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Table 3 Continued
Gene Mutant Locus
ABACUS (pool
of 933 mutants)
Competition with wt
(single mutant)
  
 
ratio
spleen /
input p-value CI
standard
error p-value
Spleen 0.13 2.E-10 0.81 0.04 5.E-03
Liver   1.34 0.05 6.E-01ΔsroA::kan
Cecum      
Spleen   0.24 0.04 <1.E-7
Liver   0.21 0.05 4.E-03
sroA
ΔsroA::FRT
Cecum   0.09 0.25 4.E-03
Spleen 2.3 6.E-06 1.67 0.04 3.E-03
Liver   1.23 0.17 7.E-01ΔoxyS::kan
Cecum      
Spleen   1.74 0.06 3.E-03
Liver   1.34 0.07 2.E-02
oxyS
ΔoxyS::FRT
Cecum   0.68 0.29 8.E-01
Spleen 0.5 6.E-04 1.79 0.09 2.E-02
Liver   1.24 0.14 4.E-01rybB ΔrybB::kan
Cecum      
Spleen 0.35 1.E-07 1.03 0.02 1.E-02
Liver   0.63 0.06 4.E-03sraA ΔsraA::kan
Cecum      
Spleen 0.47 1.E-02  0.18  0.05  8.E-05
Liver   0.05  0.37 3.E-02 tatC ΔtatC::kan
Cecum   0.03  0.14 1.E-04 
In order to definitively link the deleted genes to the reduced fitness phenotype,
two of our unmarked mutants (∆STM2303::FRT and ∆STM3121::FRT) were re-tested
after complementation in trans.  Intact copies of these genes were cloned into a stable
low copy plasmid vector, pWSK29 [176] , and the complementing plasmids were
transformed into the corresponding unmarked deletion strains. The fitness defect of both
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mutants was reversed when these strains were complemented with an intact copy of the
corresponding gene in trans and retested in competitive infections with wild-type
ATCC14028 in BALB/c mice. (Figure 10). The presence of the vector alone did not
improve the fitness of these two mutants during infection.
Figure 10: Complementation of ∆STM2303::FRT and ∆STM3121::FRT Mutants in
trans. For complementation experiments animals were infected with either a 1:1 mixture
of the mutant bearing pWSK29 vs. wild-type ATCC14028 ∆phoN::KanR (negative
control, blue bars) or the mutant bearing the corresponding complementing gene on
pWSK29 vs. the wild type ATCC14028 ∆phoN::KanR (complemented, grey bars).
ABACUS prediction for selected mutants (black bars).
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Materials and Methods
Strains and Standard Culture Conditions
All strains used in this study are derivatives of Salmonella enterica serovar
Typhimurium ATCC14028 (Manassas, VA). Strains were routinely cultured in Luria-
Bertani (LB) broth and plates, supplemented with 50 mg/l Kanamycin (Kan), 20 mg/l
Chloramphenicol (Cm) or 100 mg/l Ampicillin (Amp) where appropriate.
Construction of Plasmids with T7 RNA Polymerase Promoters.
We used a PCR-based strategy to include a T7 promoter in the original pKD3
(CmR) and pKD4 (KanR) vectors for the lambda-red recombination method. Briefly,
pKD3 and pKD4 were used as template for independent PCR reactions using primers
PT72_EcoRI
(ACTCGAATTCCGAAATTAATACGACTCACTATAGGGAGACCTAAGGAGG
ATATTCATATG) and FRT3-EcoRI
(CATCGAATTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCG
GCGCGCCT) or primers PT72-EcoRI and FRT4-EcoRI
(CATCGAATTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCA
GAGCGCT), respectively. The EcoRI sites are underlined and the PT7 is in bold. Each
PCR product was digested with EcoRI, gel purified and self ligated. Electrocompetent E.
coli EC100D pir-116 (Epicentre), was transformed with aliquots of the ligation, and
transformants were selected at 37ºC on LB Cm or LB Kan plates. The sequence (both
strands) of the resulting plasmids pCLF3 and pCLF4 was determined by the
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conventional dye-terminating Sanger method, and deposited under GenBank accession
numbers EU629213 and EU629214, respectively.
Generation of Specific Deletion Mutants
Deletion strains were generated using the lambda-red recombinase method [157],
with the following modifications, as illustrated in Figure 4. Plasmids pCLF3 (CmR) and
pCLF4 (KanR) were used as templates to generate unique PCR products for deletion of
each gene of interest. PCR amplifications were carried out in 96 well plates using ExTaq
polymerase (Takara) in a total reaction volume of 60 µl, and a PCR reaction of 30 cycles
at an annealing temperature of 55°C. For each gene to be deleted, 30 µl of both PCR
products bearing different antibiotic markers were combined and purified using the
Qiaquick PCR purification kit in 96 well format (Qiagen). Mixed, purified PCR products
(10 µl) were dialyzed against sterile water for 10 minutes using filters with 0.025 µM
pore size (Millipore). 2-5 µl of mixed, purified PCR products were used for
transformation by electroporation (Bio-Rad Gene Pulser) of electrocompetent
ATCC14028 expressing lambda-red recombinase, prepared as previously described
[157]. Transformations were allowed to recover for 3 hours in LB at 37°C and 150 µl of
each transformation was plated on LB Kan and LB Cm plates. The remaining
transformation was saved and replated when very few colonies were obtained using the
shorter grow out period. Two transformants for each gene and each antibiotic resistance
marker were twice colony purified, and stored in 30% glycerol at -80°C. The KanR
mutants characterized here are available to the community.
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Labeling Technique, Part I: DNA Isolation, Sonication and Polyadenylation
Our labeling protocol is outlined in Figure 6. Genomic DNA was prepared for
the input and output pools of ~1000 mutants using the GenElute Bacterial Genomic
DNA kit (Sigma). 4 µg of genomic DNA was fragmented by sonication using twenty
pulses of two seconds in a Branson Sonifier 150 (Branson Ultrasonics Corp., Danbury,
CT).  PolyA tails were added to fragmented genomic DNA using terminal transferase
(TdT) as follows: 1.5 µg of DNA fragments were incubated for 30 min at 37°C in a total
reaction volume of 50 µl containing 40 U TdT (New England BioLabs.), CoCl2 0.25
mM, and dATP 0.4 mM. Terminal transferase was subsequently inactivated at 70°C for
10 min and the tailed product was purified using the QIAquick PCR purification kit
(Qiagen).
Labeling Technique, Part II: PCR Amplification and Labeling of Fragments Adjacent
the Deletion Location
Nested PCR was used to amplify the polyA-tailed DNA fragments containing the
insert PT7 and the flanking inserted region. In the first PCR reaction, 50 ng of purified
polyA-tailed DNA was used as template for a PCR reaction using primer FRT Out 3-1
(TTCCTATACTTTCTAGAGAA), and a primer designed to anneal to the polyA-tail
(CCT24VN). The reaction mixture consisted of 1X PCR buffer, 0.2 mM of dNTP, 1.5
mM MgCl2, 0.05 U Taq polymerase (Promega, WI), and 0.2 µM of each forward and
reverse primer in a total reaction volume of 25 µl. The PCR reaction was performed
under the following conditions: initial denaturation at 94°C for 1 min followed by 30
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cycles with denaturation at 94°C for 10 s, annealing at 50°C for 10 s, and extension at
72°C for 5 s. The last cycle was followed by a final extension for 3 min at 72°C. In the
second amplification step, a nested PCR was performed using 1 µl amplified product
from the initial PCR in a total volume of 50 µl. Internal primer FRT Out 3-2
(TAGGAACTTCGGAATAGGAA) and primer CCT24VN were used under identical
cycling conditions as during the initial PCR reaction. PCR products were analyzed on
1% agarose gels.
An aliquot of 8 µl of the nested PCR reaction was used directly as template for a
20 µl in vitro transcription reaction using the AmpliScribe T7 transcription kit
(Epicentre), following the manufacturer’s protocol with some modifications. The RNA
was labeled during the synthesis by including 2 µl of 5 mM Cy5- or Cy3-UTP (GE
Healthcare) in the in vitro transcription reaction. Labeled RNA was treated with RNase-
free DNase (Epicentre) and purified with the RNeasy Mini Kit (Qiagen).
NimbleGen Microarray Hybridization
Hybridizations were performed according to the manufacturer’s protocols
(NimbleGen Systems, Madison, WI, http://www.nimblegen.com/products/lit/lit.html,
cgh_userguide_2008_05_27[1].pdf) with some modifications. For each hybridization, 4
µg of labeled RNA was mixed with alignment oligo, NimbleGen hybridization
components and hybridization buffer. The arrays were hybridized at 42°C for 16 hours.
Arrays were washed according to the manufacturer’s protocol, and scanned using a
GenePix 4000B laser scanner (Molecular Devices, Sunnyvale, California) at 5 µm
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resolution. The signal intensities were quantified using NimbleScan software v2.4
(NimbleGen Systems). The data was normalized and analyzed using Webarray and
WebarrayDB with quantile normalization [175]. The moving median intensity of five
adjacent probes on the same strand in the genome was calculated and plotted against the
genome annotation. Peaks were identified visually [171].
In-house Array Hybridization
The 933 65mer 3’ oligos and over 1000 control oligos were printed at 10 µg/ml
in 50% DMSO on Corning UltraGap II slides in triplicate arrays. Oligo sequences can be
found in supplementary information [171] and the arrays deposited in GEO as platform
GPL5687 and GPL5688. Array hybridization was performed in hybridization chambers
(Corning Inc., Corning, NY), following protocols suggested by the manufacturer for
hybridizations in formamide buffer for pre-hybridization, hybridization, and post-
hybridization washes
(http://www.corning.com/Lifesciences/technical_information/techDocs/gaps_ii_manual_
protocol_5_02_cls_gaps_ 005.pdf). Immediately before hybridization, 2 µg of the
labeled probes for input and 2 µg of each experimental sample were unified in 36.5 µl,
mixed with 3.5 µl of 100 µM 27mer competitor oligo
(CATATGAATATCCTCCTTAGGTCTCCC), and 40 µl of 2 X hybridization buffer
(50% formamide, 10 X SSC [1 X SSC is 0.15 M NaCl plus 0.015 M sodium citrate],
0.2% sodium dodecyl sulfate) and then denatured at > 96°C for 5 min. The probes were
hybridized to the Salmonella microarray overnight at 42°C in a water bath.
67
After overnight incubation, slides were washed and scanned using the ScanArray 5000
laser scanner (Packard BioChip Technologies, Billerica, Mass.) with ScanArray 2.1
software. Fluorescence signal intensities were quantified using the QuantArray 2.0
software package (Packard BioChip Technologies). The data were subsequently
analyzed using Webarray [175] (www.webarraydb.org), with quantile normalization.
Recombination Between FRT Sites Using FLP Recombinase
Antibiotic resistance cassettes were removed from targeted deletion mutants as
previously described  [157]. Briefly, each mutant was transformed with the temperature-
sensitive plasmid pCP20, that encodes FLP recombinase [177]. Transformants bearing
the plasmid were selected at 30°C on LB Ampicillin plates. Several colonies from each
transformation were streaked twice and grown at 37°C on LB plates (without
antibiotics).  Loss of the antibiotic resistance cassettes was determined by patching
candidate strains on LB containing the appropriate antibiotics (either Kan or Cm). The
concomitant loss of plasmid pCP20 was confirmed by patching the candidate mutants on
LB Amp plates.
In our mutant collection, the recombination event leaves a “scar” of ten codons
from the 5’ end of the original gene, a 39 codon region containing the PT7, and the final
ten codons of the original gene (Figure 5). Scarred derivatives of mutants
ΔSTM0854::kan, ΔSTM1402::kan, ΔSTM2840::kan, ΔSTM2884::kan, ΔSTM2581::kan
and ΔSTM2581::cam were generated to ensure the accuracy of FLP recombination. The
presence of each scarred mutant allele was confirmed by PCR amplification using
68
primers flanking mutation, and the subsequent sequence of both strands of the PCR
product was obtained by the conventional dye-terminating Sanger method. Non-resistant
scarred derivatives of mutants ΔleuX::kan, ΔsroA::kan, ΔistR::kan, ΔoxyS::kan,
ΔSTM1131::kan, ΔSTM2303::kan, ΔSTM3120::kan, and ΔSTM3121::kan were generated
for further testing in mice.
Construction of Complementing Plasmids
STM2303 was amplified for complementation using the following primers:
STM2303 forward primer 5’ GGCGTCTGGTACCAATTCAGTAT 3’, and STM2303
reverse primer 5’ TGTTCTGGATCCGTGCGATAGC 3’.  The resulting 947 base pair
PCR product, in which the only full length ORF is STM2303, was purified using agarose
gel electrophoresis and extracted from the gel using the Qiaquick gel extraction kit
(Qiagen). STM3121 was amplified for complementation using the following primers:
STM3121 forward primer 5’ GCTATTTTCAGGGTACCGTTTGGTCG 3’, and
STM3121 reverse primer 5’ GCTCCGTTAGCGGATCCTTTAGACAC 3’. The
resulting 1266 base pair PCR product was purified by agarose gel electrophoresis, and
extracted from the gel using the Qiaquick gel extraction kit (Qiagen). The PCR product
contains the full-length STM3121 open reading frame (879 bp) with approximately 296
bp of upstream and 90 bp of downstream sequence.
Purified PCR products were digested with KpnI and BamHI and ligated into
pWSK29 previously cut with the same enzymes and gel purified. E. coli DH5a was
transformed with each ligation, and positive clones were selected on LB plates
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containing Ampicillin. Plasmids bearing the correct insert from each cloning were found
by identification of fragments of the proper size after digestion with PvuI.  pWSK29,
pWSK29::STM2303, and pWSK29::STM3121 were transformed into S. Typhimurium
strain LB5000 (restriction-, modification+) [178]. Plasmid DNA was prepared from
LB5000 plasmid-bearing transformants using the Qiaprep spin Miniprep kit (Qiagen),
and purified plasmid DNA was used to transform ∆STM2303::FRT and
∆STM3121::FRT mutants using heat shock.  Plasmid-bearing deletion mutants were
selected on LB Amp plates, and were twice colony purified prior to use for infections.
Animal Studies in BALB/c Mice
The pools of ~1,000 mutants used as inocula were grown overnight at 37°C in
LB with aeration and serially diluted in PBS to the proper concentration for inoculation,
and the titer of the inoculum was determined by plating on LB containing Kanamycin. A
group of 6 BALB/c mice (8-10 week old female) was infected intraperitoneally with 1 x
106 CFU of the pool in 100 µl PBS. Mice were monitored twice daily for signs of
infection, and were humanely euthanized at 48 hours post infection. Immediately after
euthanasia, the spleen was removed and homogenized in 5 ml sterile ice cold PBS. 100
µl of the spleen homogenate was used for serial dilution and titer on LB Kan plates. The
bacteria in the remaining homogenate were grown in LB to stationary phase and total
DNA was extracted.
Individual mutants with an apparent phenotype in the pools were chosen for
confirmation in mixed infections with wild-type strain HA431 (ATCC14028 phoN
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NalR), to determine the competitive index. Inactivation of phoN, encoding alkaline
phosphatase, abolishes the ability to cleave 5-bromo-4-chloro-3-indolyl phosphate (XP),
but does not reduce the ability of serotype Typhimurium to colonize organs or reduce
fecal shedding of this organism in mice during competitive infections [32]. Growth on
LB agar plates supplemented with XP thus provided an easy means to distinguish
between individual mutants (PhoN+ blue colonies) and HA431 (PhoN- white colonies).
Prior to further analysis, the mutant allele present in each individual mutant to be
confirmed was transferred to HA420 (ATCC14028 NalR) by P22 transduction. Mutant
strains and our wild type strain HA431 were grown overnight at 37°C with aeration,
mixed in a 1:1 ratio, and serially diluted in PBS to the proper concentration for
inoculation and titer. Titer was used to determine the exact ratio of strains administered.
Groups of 4-6 BALB/c mice (8-10 week old female) were infected intraperitoneally with
1 x 106 CFU of mutant and wild-type virulent HA431 in 100 µl PBS. Mice were
euthanized and spleens, livers, and ceca were recovered as above. Mutant and wild-type
organisms were enumerated by serial dilution and plating on LB plates containing 20
mg/L of XP.
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CHAPTER III
ABROGATION OF THE TWIN ARGININE TRANSPORT SYSTEM IN
LEADS TO ATTENUATION
Introduction
Human infection with Salmonellae, both typhoidal and non-typhoidal serotypes,
results in approximately 3 million deaths per year worldwide [1].  Infection with non-
typhoidal serotypes, such as Salmonella enterica serotype Typhimurium, occurs after
ingestion of contaminated food or water and leads to self-limiting gastroenteritis in
otherwise healthy individuals.
S. enterica, like other gram negative organisms, is dependent upon secretion of
proteins beyond the outer membrane via several different types of secretion systems for
many functions. The Type Three Secretion Systems (TTSS) encoded in Salmonella
Pathogenicity Islands (SPI) I and II are specialized secretion systems for the injection of
effectors into eukaryotic cells. These systems secrete effectors through needle-like
structures and enable the bacteria to invade epithelial cells (TTSS1) and promote
survival within the vacuole of host cells (TTSS2) [36,137,138,179,180,181,182].
Salmonellae also utilize the general secretory pathway (GSP) for the secretion of many
bacterial factors, including some virulence related proteins including MisL, an
autotransporter protein [183]. The GSP requires the Sec translocase for secretion across
the inner membrane and other secreton machinery for moving proteins from the
periplasm across the outer membrane.
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A third type of secretion system, the twin arginine transport (Tat) system is
required in many organisms for the transport of folded proteins from the bacterial
cytoplasm into the periplasm. The Salmonella enterica serotype Typhimurium twin
arginine transport system encoded by the Tat operon has ~80% identity to the Tat operon
in E. coli. This ubiquitous system transports substrates containing a positively charged
N-terminus with the canonical signal sequence S/T-R-R-x-F-L-K N-terminal to a weakly
hydrophobic core of approximately 38 residues and a “Sec avoidance” signal upstream
of a peptidase cleavage site[184,185,186,187]. The Tat secretion system machinery
includes 3 major components, TatA, B and C. TatA is found in molar excess and is
responsible for formation of the pore through which folded proteins traverse the
membrane [188]. TatB plays a role in recognition of the signal sequence of substrates
and interaction of TatA with TatC [189]. TatC is the largest component of this transport
apparatus [190,191,192] and is highly conserved, especially at the termini and other
cytoplasmic domains [193,194,195]. Initial docking of the signal sequence occurs via
TatC [196]. While many of the substrates of the Tat system are cofactor-containing
redox enzymes, the particular substrates predicted to be transported by the Tat system in
different organisms are quite variable [197]. The Tat system of Salmonella is predicted
to transport approximately 30 proteins into the periplasm, including one substrate that
lacks a twin-arginine that is Salmonella specific, TtrB [94,198].
We became interested in the Tat system in Salmonella when we identified ΔtatC
mutants as selected against in a screen for mutants under selection during systemic
infection [171]. In the current study, we explore the effects of deletion of tatC in
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Salmonella enterica serovar Typhimurium ATCC14028 during infection. We confirm
that ΔtatC mutants are impaired for colonization of systemic organs after intraperitoneal
delivery in Salmonella-susceptible BALB/c mice, and they are internalized by J774-A.1
murine macrophages in lower numbers than the isogenic wild type parental isolate,
ATCC14028. We also studied the ability of ΔtatC mutants to colonize the intestinal tract
and spread systemically after oral delivery and we show that these mutants are highly
sensitive to bile acids. Finally, we show that ΔtatC mutants have an unusual motility
defect; they are unable to swim yet they swarm similar to wild type ATCC14028.
Results
∆tatC Mutants Are Attenuated in a Systemic Model of Infection
In a previously performed genetic screen, we identified a large group of mutants
that were not described as important for Salmonella growth during infection [171].
Deletion mutants in tatC were identified in this screen as potentially selected against
during systemic infection in Salmonella-susceptible BALB/c mice. We confirmed that
TatC is required for systemic infection after intraperitoneal inoculation using
competitive infections between ΔtatC mutants (HA473 ATCC14028 NalR ΔtatC::KanR)
and wild type (HA431 ATCC14028 NalR ΔphoN::KanR). In these experiments, ΔtatC
mutants had a reduced ability to colonize the liver and spleen 48 hours after
intraperitoneal infection of either Salmonella-susceptible BALB/c mice or Salmonella
resistant CBA/J mice (Figure 11). Using intraperitoneal inoculation, the infecting strains
bypass the intestinal tract, a niche that non-typhoidal Salmonella must survive during
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most naturally acquired infections.  Thus, the ΔtatC mutants are defective for
colonization and replication in systemic sites even when they are delivered by a route
that bypasses the intestine.
Figure 11: ΔtatC is Attenuated in Salmonella-Susceptible and Resistant Mice After
Inoculation by the Intraperitoneal Route. Mice were infected with an equal ratio of
HA473 (ATCC14028 ΔtatC:: KanR ) and HA431(ATCC14028 NalR ΔphoN:: KanR) by
intraperitoneal inoculation with 1x106 bacteria for 2 days in BALB/c (A), or CBA/J (B).
Analysis of CFU in the cecum (C), spleen (S), and liver (L) showed that ΔtatC mutants
have reduced fitness in both Salmonella-sensitive (BALB/c) and Salmonella-resistant
(CBA/J) mouse models, *p<0.05, **p<0.005.
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ΔtatC Mutants Are Defective During Infection of J774-A.1 Macrophages
The ability to adhere to, invade and replicate in eukaryotic cells, notably
macrophages, is intimately associated with the pathogenesis of ssp. I serotype
Typhimurium [199], and is important for virulence and systemic colonization by this
organism [60,200]. We postulated that the defect of ∆tatC mutants in systemic
colonization after intraperitoneal infection might be due to a defect in internalization
and/or survival within macrophages. To test this hypothesis we compared ∆tatC mutants,
wild type ATCC14028 (HA420 NalR), and isogenic ∆invA mutants for adherence,
internalization by and replication in J774-A.1 macrophages. In these assays, ∆tatC
mutants were defective in cell association, invasion and intracellular replication when
compared to wild type ATCC14028. The ability to adhere to cells, become internalized
by them and replicate was restored when tatC was supplied in trans (Figure 12).
To rule out the possibility that the defects of the ΔtatC mutants association and
internalization by macrophages were the result of an inability to come into close
proximity with J774-A.1 cells, we repeated our experiments using low speed
centrifugation to force the bacteria into close contact with J774-A.1 cells. Despite this
treatment, the ∆tatC mutant was still defective for cell association, and was internalized
more poorly than the isogenic wild type ATCC14028 (Figure 12).
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 Figure 12: ΔtatC Mutants are Defective For Internalization and Replication within
Macrophages.  J774-A.1 macrophages were infected in a gentamicin protection assay in
order to examine ability of ΔtatC mutants to associate with and be internalized by
cultured macrophages. ΔtatC mutants had reduced cell association and internalization by
J774-A.1 macrophages whether centrifugation was used or not (A). Mutants were
somewhat defective after 24 hours (B). The phenotype was complemented by addition of
a plasmid containing functional tatC. The data shown is a combination of three
independent experiments. Data for each strain was averaged and compared to the
corresponding wild type data point in a student’s two-tailed T-test. *p<0.05, **p<0.005.
∆tatC Mutants Poorly Colonize the Intestinal Tract
We also assayed the ability of ΔtatC mutants to colonize and persist in the
intestinal tract of mice, both during short-term infections and for prolonged periods of
time. In our short-term infections, we infected BALB/c mice orally with an equal
mixture of wild type ATCC14028 and ∆tatC mutant and evaluated colonization by both
strains at 5 days post-infection. ∆tatC mutants were highly defective for colonization of
the intestinal tract and spread to systemic organs in this model (Figure 13).
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Figure 13: ΔtatC is Attenuated in Salmonella-Susceptible Mice After Inoculation by
the Oral Route. Salmonella-susceptible mice were infected with an equal ratio of
HA473 (ATCC14028 ΔtatC::KanR) and HA431 (ATCC14028 NalR ΔphoN::KanR) by
oral gavage with 1x109 bacteria for 5 days. Analysis of CFU in the Peyer’s patches (PP),
mesenteric lymph nodes (MLN), cecum (C), spleen (S), and liver (L) showed that ΔtatC
mutants are unfit in different methods of infection. Data may indicate extracellular
bacteria, as well as intracellular bacteria, *p<0.05.
To evaluate colonization of the intestinal tract for longer periods of time, we
followed fecal shedding of ∆tatC mutantsand the isogenic wild type ATCC14028 in
Salmonella-resistant CBA/J mice that were infected by the oral route. We infected
CBA/J mice orally with an equal mixture of ΔtatC mutants and the isogenic wild type
and monitored fecal shedding in these mice for 40 days post infection. These mice
possess a functional NRAMP allele, and do not develop systemic salmonellosis, although
they are colonized by serotype Typhimurium in the gastrointestinal tract [7,8,9,11,201].
∆tatC mutants had 10-fold reduced fecal shedding from CBA/J mice at early
time points post infection, as compared to wild type ATCC14028 (Figure 14A),
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consistent with our previous results showing reduced intestinal colonization by ΔtatC
mutants in BALB/c mice. Furthermore, this defect became more severe with longer
duration post infection (Figure 14A). At 40 days post infection ΔtatC mutants were not
detectable in the feces of any of the infected mice (5/5 mice). In the organs of infected
mice at the termination of the experiment, the majority of the bacterial load was found in
the cecum and this population overwhelmingly consisted of wild type Salmonella
(Figure 14B).
 Figure 14: ΔtatC Mutants are Attenuated in Salmonella- Resistant Mice After Oral
Infection. Mice were infected with an equal ratio of HA473 (ATCC14028 ΔtatC::KanR)
and HA431 (ATCC14028 NalR ΔphoN::KanR) by oral gavage with 1x109 bacteria (A and
B). Fecal samples of six mice were analyzed over 40 days (A) after which the Peyer’s
patches (PP), mesenteric lymph node (MLN), cecum (C), spleen (S), and liver (L) were
collected (B). ΔtatC mutants are heavily attenuated compared to wild type even at early
time points. Organ data may indicate extracellular, as well as intracellular bacteria,
*p<0.05, **p<0.005.
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ΔtatC Mutants Are Highly Sensitive to Bile Acids
Because ∆tatC mutants are defective for intestinal colonization in murine models
at very early time points after oral infection, we explored sensitivity to bile acids as a
possible reasons for this phenotype. In E. coli, ∆tatC mutants are susceptible to detergent
due the inability to secrete amiA and amiC [202,203,204]. We hypothesized that
Typhimurium ∆tatC mutants may also be more susceptible to detergent killing.
We tested this hypothesis by evaluating the susceptibility of our ∆tatC mutants to
the bile acid deoxycholate in vitro (DOC, 1%) [205]. Bacteria were grown in rich media
overnight, sub-cultured in LB broth, grown to mid-log phase, and serial dilutions were
plated on LB plates with or without 1% DOC. Both the wild type and ΔtatC mutant grew
equally well on LB plates without added DOC, yet the ∆tatC mutant had dramatically
reduced survival (>99%) on DOC as compared to the isogenic wild type (Figure 15).
We show that the presence of a functional Tat system is responsible for this defect, as
returning an intact copy of the tatC gene in trans restores the ability of this strain to
survive 1% DOC at levels similar to the isogenic wild type. On this basis, we suggest
that ∆tatC mutants are simply poorly able to survive exposure to bile acids upon transit
of the upper small intestine during infection. This poor survival in the upper small
intestine results in a defect in colonization of the lower intestinal tract, and reduced
levels of fecal shedding.
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 Figure 15: ΔtatC Mutants are Sensitive to Bile Acids. HA420 (ATCC14028) HA473
(ATCC14028 ΔtatC::KanR)  and HA640 (ΔtatC::KanR bearing tatC in trans) were grown
to stationary phase, subcultured and grown to mid-log phase before diluting and spotting
on plates containing either 0% or 1% DOC. ΔtatC mutants have reduced viability after
treatment with 1% DOC. The samples shown are representative of three independent
experiments.
Altered Motility of ∆tatC Mutants Is a Result of Ability to Express Flagellins on the
Surface of Salmonella
As part of a larger screen for motility defects, we also observed ∆tatC mutants
had a very unusual phenotype.  These mutants are defective for swimming motility, but
are able to swarm well (Figure 16). ∆tatC mutants complemented in trans with the tatC
open reading frame, under the control of an arabinose inducible promoter, restored the
ability of these mutants to swim normally (Figure 16A). We examined the ability of
these mutants incubated in various in vitro conditions to produce and elaborate
flagellins, FliC and FljB, on the bacterial surface.
-1% DOC +1% DOC
Wild Type
ΔtatC
ΔtatC + pBAD tatC
(60.7% +/- 7.7)
(99.9% +/- 0.01)
(44.8% +/- 7.2)
10-1 10-110-3 10-310-5 10-5
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Figure 16: ΔtatC Mutants Swarm, but Do Not Swim. 1) HA630 (ATCC14028s NalR +
pBAD vector CarbR) 2) HA634 (ATCC14028s NalR + pBAD tatC CarbR) 3) HA636
(ATCC14028s NalR ΔtatC::KanR + pBAD vector CarbR) and 4) HA640 (ATCC14028s
NalR ΔtatC::KanR + pBAD tatC CarbR) were plated on (A) swimming (0.3% agar) and
(B) swarming (0.6% agar, 0.5% glucose) motility plates and incubated at 370C for 5 and
7 hours respectively. Assays were performed in triplicate on three separate occasions.
Wild type ATCC14028, elaborates the flagellins on the bacterial surface during
all three conditions we tested:  at stationary phase in LB broth, after incubation on
swimming motility agar, and after incubation on swarming motility agar (Figure 17A,
B, and C, lane 3). The level of flagellins elaborated on the bacterial surface of ∆tatC
mutants and isogenic wild type ATCC14028 incubated on swimming and swarming agar
plates for 5-7 hours was compared. ∆tatC mutants grown in LB broth or incubated on
swimming plates have very little of either flagellin, FliC or FljB on their surfaces
(Figure 17A and B, lane 4). The level of flagellins on the surface of ∆tatC mutants was
restored to the level of the isogenic wild type when the mutant was complemented in
trans with an intact copy of tatC (Figure 17A and B, lane 5). Thus, ∆tatC mutants have
1 2
3 4
A. B.
1 2
3 4
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reduced motility on swimming motility agar as they likely produce fewer flagella in
these conditions.
Figure 17: Flagellins in ΔtatC Mutants are Decreased Under LB and Swimming
Conditions, but Increased Under Swarming Conditions. Bacteria from 1) HA478
(ATCC14028s NalR ΔfliC::KanR), 2) HA690 ATCC14028s NalR ΔfljB::KanR), 3) HA420
(ATCC14028s), 4) HA473 (ATCC14028s NalR ΔtatC::KanR), and 5) HA640
ATCC14028s NalR ΔtatC::KanR + pBAD tatC CarbR) were harvested from LB broth,
0.6% agar plates used to assay swarming motility and 0.3% agar plates used to assay
swimming motility. Flagellins were sheared from the surface for Western analysis. The
sheared fractions from LB (A), swimming conditions (B), and swarming conditions (C)
were probed with α-FliC and α-FljB. The whole cell lysate for each sample was stained
with Coomassie Brilliant blue to control for loading of the sheared fractions. The whole
cell fraction was probed with α-FliC (D) to determine whether ΔtatC mutants were
defective in production of flagellins. The samples shown are representative of three
independent experiments.
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On swarming motility agar, ΔtatC mutants are motile (Figure 16B, 3), and they
are able to elaborate flagellins on their surface when incubated on media for swarming
motility (Figure 17C, lane 4). Thus, they appear to produce flagella when they are
swarming. This data indicates that a general defect in the ability to export flagellins to
the bacterial surface is unlikely to be the cause of the reduced amount of flagellins
observed on the surface of ∆tatC mutants grown in LB broth or incubated on swimming
motility agar. Our data show that ΔtatC mutants are able to elaborate flagellins on the
bacterial surface under particular conditions, indicating that their lack of motility on
swimming motility agar is not simply due to a blanket inability to produce flagellins and
assemble flagella on the bacterial surface.
The Predicted Substrates of the Tat System in Two Closely Related Species Are Highly
Varied
Utilizing a published genomic survey of prokaryotes we compared potential
substrates of the Tat system in two closely related species, Salmonella enterica and E.
coli. [197] Approximately 40% of the predicted substrates differ between the 2
organisms (Table 4), including 2 substrates encoded on Salmonella pathogenicity island
2 (SPI-2) but not part of the type III secretion system, ttrA and ttrB. Three substrates in
E.coli have homology to duplicate genes in Salmonella, possibly due to large conserved
domains in these enzymes (Table 4). A few protein sequences contain non-canonical
signal sequences that were either predicted to be transported or shown experimentally.
By comparing these two species, we can infer that even though they are closely related,
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the Tat system may transport proteins that fulfill different functions in different
organisms for the same purposes in both organisms.
Table 4: Comparison of Putative Tat Substrates between Salmonella and E. coli.
Based on Dilks et al.[197] Bold denotes differences between species, * denotes twin
arginine present, but not recognized as a signal sequence, ** denotes no twin arginine,
but demonstrated to be a substrate [198], and superscripted letter denotes gene
duplication.
Salmonella
gene #
Salmonella
gene  name
Tat
signal
(y/n)
E. coli
gene #
E. coli gene
name
Tat
signal
(y/n) Function
STM0060 citE2a y b0616 citE y citrate lyase beta chain
STM0070 caiD n b2919 scpB y methylmalonyl-CoA decarboxylase
STM0084 aslA y b3678 yidJ n putative sulfatase
STM0107 thiP y b0067 thiP y thiamine transporter, ABC family
STM0168 cueO y b0123 cueO y multicopper oxidase
STM0193 fhuD y b0152 fhuD y hydroxamate dependent iron uptake
STM0611 ynfEb y b1587 ynfE y oxidoreductase
STM0622 citE a y b0616 citE y citrate lyase beta chain
STM0834 ybiP y b0815 ybiP n putative integral membrane protein
STM0964 dmsA y b0894 dmsA y dimethyl sulfoxide reductase, A
STM0996 ycbK y b0926 ycbK y putative outer membrane protein
STM1383 ttrA y tetrathionate reductase (SPI-2)
STM1385 ttrB y** tetrathionate reductase (SPI-2)
STM1498 ynfF y b1588 ynfF y putative dimethyl sulfoxide reductase
STM1499 ynfEb y b1587 ynfE y putative dimethyl sulfoxide reductase
STM1539 hyaAc y b0972 hyaA y hydrogenase 1, small subunit
STM1570 fdnG y b1474 fdnG y formate dehydrogenase
STM1622 ydcG/mdoD y b1424 ydcG/mdoD y glucans biosynthesis
STM1710 pgpB n* b1278 pgpB y phosphatidylglycerophosphate phosphatase
STM1786 hyaAc y b0972 hyaA y hydrogenase 1, small subunit
STM2064 phsB n b1671 ydhX y putative oxidoreductase
STM2065 phsA y hydrogen sulfide production
STM2099 wcaM y b2043 wcaM y putative colanic acid biosynthesis
STM2258 napG y b2205 napG y ferredoxin, electron transfer
STM2259 napA y b2206 napA y periplasmic nitrate reductase
STM2446 n b1019 efeB/ycdB y putative iron dependent peroxidase
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Table 4 Continued
Salmonella
gene #
Salmonella
gene name
Tat
signal
(y/n)
E. coli
gene #
E. coli gene
name
Tat
signal
(y/n) Function
STM2450 amiA y b2435 amiA y N-acetylmuramoyl-L- alanine amidase I
STM2991 amiC y b2817 amiC y N-acetylmuramoyl-L- alanine amidase
STM3058 pepP y b2908 pepP n* proline aminopeptidase II
STM3149 hybA y b2996 hybA y putative hydrogenase
STM3150 hypO y b2997 hybO y putative hydrogenase
STM3172 sufI y b3017 sufI y suppressor of ftsI
STM3377 yedY y b1971 yedY y putative nitrate reductase
STM3615 yhjK n b1163 ycgF y putative phosphodiesterase
STM3644 bisC n b1872 torZ y biotin sulfoxide reductase 2
STM3822 torA y b0997 torA y TMAO reductase
STM4037 fdoG y b3894 fdoG y formate dehydrogenase
STM4190 pepE y b4021 pepE y alpha-aspartyl dipeptidase
STM4279 nrfC y b4072 nrfC y formate dependent nitrate reductase
STM4557 holD y b4372 holD y DNA polymerase III, psi subunit
PSLT024 y hypothetical protein
PSLT046 y b0126 can n putative carbonic anhydrase
PSLT067 n b0249 ykfF y hypothetical protein, CP4-6 prophage
b0286 yagT y putative xanthine dehydrogenase
b0324 yahJ y putative deaminase
b0705 ybfL y pseudogene
Deletion of RcsB Partially Restores Motility to ∆tatC Mutant
It has recently been shown that the master operon for flagellar synthesis, flhDC,
is negatively regulated by RcsB [206]. The Rcs regulon is up-regulated in ΔtatC mutants
in response to cell wall defects [207] that can occur in these mutants. In order to
determine whether Rcs is involved in the motility defect seen in ∆tatC mutants under
swimming conditions, rcsB was deleted in a ΔtatC background. We hypothesized that if
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RcsB repression of flhDC is responsible for the motility defect, then deletion of rcsB
should lead to a rescue of both swimming and surface flagellins. We compared wild type
parental isolate, the ∆tatC mutant, and a double ∆tatC ∆rcsB mutant on swimming
motility agar. We observed that deletion of rcsB partially rescued the motility phenotype
we observed in ∆tatC mutant (Figure 18). Furthermore, deletion of rcsB also partially
rescued export of flagellins to the bacterial surface in the ∆tatC ∆rcsB double mutant.
Figure 18: Deletion of rcsB Partially Rescues ΔtatC Defects in Motility and Flagellin
Secretion. RcsB, an inhibitor of the master flagellar regulator, was deleted in a ΔtatC
background and tested for swimming motility (A) and ability to elaborate FliC flagellins
on the surface of Salmonella (B).
WCE
Sheared
WT ΔtatC ΔtatC ΔrcsBWT ΔtatC
ΔtatC ΔrcsB
A. B.
α-FliC
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Materials and Methods
Bacterial Strains and Plasmids
The strains used in this study were derived from Salmonella enterica serovar
Typhimurium ATCC14028. We generated a spontaneous nalidixic acid resistant
derivative of ATCC14028, HA420, that is virulent and persistent in murine models
[150]. All deletion mutants were generated by the lambda red method of Datsenko and
Wanner [157]. Deletion mutants that were studied in animal models were first moved
into a clean genetic background by P22 transduction.
Strains were routinely cultured in Luria-Bertani (LB) broth and plates,
supplemented with 50 mg/L nalidixic acid, 100 mg/L carbenicillin and 50 mg/L
Kanamycin or 20 mg/L Chloramphenicol where appropriate. For the detection of phoN
expression, 20 mg/L of 5-bromo-4-chloro-3-indolyl-b-D-phosphate (XP) was added to
LB agar plates. Strains were grown in the presence of 0.02% arabinose for over-
expression of TatC by arabinose induction. 0.5% glucose was used for catabolite
repression.
For infections in murine models, all strains were grown at 370C with aeration to
stationary phase in Luria-Bertani (LB) broth containing the appropriate antibiotics.
Strains used for invasion assays were grown statically for 16 hours at 370C in LB broth
containing 0.3 M NaCl, these conditions have been described previously to promote SPI-
1 expression [208,209]. For deoxycholate (DOC) sensitivity assays, strains were grown
overnight in LB, and sub-cultured at a dilution of 1:100 in LB until log phase was
reached (OD=0.3-0.4). Cultures were incubated in the presence or absence of 1% DOC
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[205] for 4 hours with aeration at 370C, serially 10-fold diluted and plated on LB agar
plates.
We complemented our ΔtatC mutant in trans by cloning an intact tatC open
reading frame into pBAD TOPO (Invitrogen). A fragment containing the tatC open
reading frame was amplified by PCR using the following primers: tatC Forward 5’
GGGACCGTAAACATGGCTGTA 3’ and tatC Reverse 5’
CGGTTGTGTAAAGTCTTCAGT 3’.  The 780 base pair PCR product was ligated in
frame with the pBAD promoter as well as a C-terminal fusion to a V5 epitope and
polyhistidine region by altering the stop codon (see underlined base pairs). The
orientation and frame of the cloned fragment were determined by dideoxy sequencing
using the following primers: pBAD Forward (5’ ATGCCATAGCATTTTTATCC 3’)
and pBAD Reverse (5’ GATTTAATCTGTATCAGGCT 3’).
Systemic Infection of Mice by Intraperitoneal Infection
Salmonella enterica serotype Typhimurium strains used as inocula were grown
to stationary phase at 370C with aeration and mixed in a 1:1 ratio of ΔtatC mutant to
HA431 (NalR ΔphoN::KanR), and then diluted to 1x107 CFU/ml in PBS.  Inocula were
serially diluted and titered for bacterial CFU to determine the exact ratio of both strains
in the competitive infection.
 Groups of four to six mice were inoculated intraperitoneally with approximately
1x106 bacteria in 100 µl of PBS. Two days post infection mice were euthanized and
livers, spleens, and ceca of infected mice were excised and homogenized in 5 ml ice cold
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PBS.  Organ homogenates were serially diluted and plated to determine the ratio of
ΔtatC mutant CFU versus wild type HA431 CFU from the collected tissues of infected
animals.  Data are expressed as the ratio of ΔtatC mutant CFU versus the wild type
HA431 CFU, and were normalized to the input ratio, converted logarithmically,
displayed graphically. Statistical significance was determined using a Student’s t test and
a P value of < 0.05.
Cell Association, Invasion and Intracellular Replication
The ability of ΔtatC mutants to associate with, be internalized by and replicate
within J774-A.1 macrophages was tested using the following method.  J774-A.1 cells
were propagated in DMEM (Cellgro) supplemented with10% Fetal Bovine Serum
(PAA), and plated at a density of 3.5x105 cells per well in tissue-culture treated 24 well
dishes for all infections. Bacteria used for infecting J774-A.1 macrophages were grown
to stationary phase without aeration in LB broth supplemented with 0.3M NaCl
[208,209]. The titer of the inoculum in each experiment was determined by serial
dilution and plating on appropriate bacteriologic media.
J774-A.1 Cells were infected with Salmonella at a multiplicity of infection of
50:1 (bacteria:J774-A.1), and bacteria were spun onto the cells at 750 rpm for 5 minutes
where noted (Eppendorf 5804R). Infected cells were incubated for 1 hour at 370C with
5% CO2 in a humidified tissue culture incubator. J774-A.1 monolayers were washed
three times with 1 ml sterile PBS prior to lysis, to enumerate cell associated bacteria, or
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treated with 100 µg/ml gentamicin sulfate for 1 hour at 370C with 5% CO2 in a
humidified tissue culture incubator.
 For enumeration of intracellular bacteria that were internalized by J774-A.1
cells, gentamicin was removed and monolayers were washed with 1 ml sterile PBS three
times.  Infected monolayers were lysed in 1% Triton X-100, and intracellular CFU were
enumerated by serial dilution and plating.
 For assessment of intracellular growth, infected, gentamicin treated monolayers
were washed with sterile PBS, and fresh DMEM supplemented with 10% FBS and
10µg/ml Gentamicin were incubated 24 hours post Gentamicin treatment, washed with
sterile PBS three times, lysed and intracellular CFU were enumerated.  At each stage
when infected cells were lysed, the number of viable J774-A.1 cells in duplicate infected
monolayers was assessed by 0.4% Trypan Blue (Cellgro) exclusion and counting viable
cells. Each experiment evaluated samples in triplicate, and each experiment was
performed on three separate occasions.
Organ Colonization in Salmonella-Susceptible BALB/c Mice
Mutants in tatC were tested for virulence in 8 - 10 week old female BALB/c
mice (Jackson Labs) in competitive infections with virulent Salmonella enterica
serotype Typhimurium 14028 using the following protocol.  Salmonella enterica
serotype Typhimurium strains used as inocula were grown to stationary phase at 37oC
with aeration, diluted 1:10 and mixed in a 1:1 ratio of mutant to HA431 (ATCC14028
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NalR ΔphoN::KanR) .  Inocula were serially diluted and titered for bacterial CFU to
determine the exact ratio of both strains in the competitive infection.
 Groups of four to six mice were inoculated intragastrically by gavage with
approximately 2x107 bacteria in 200 µl of LB. Infected mice were observed daily for
signs of illness and were euthanized after the development of signs, usually in 4-5 days
(inactivity and reluctance to move, ruffled fur, crouching together).   Immediately after
euthanasia, livers, spleens, Peyer’s patches, and ceca of infected mice were excised and
homogenized in 5 ml ice cold PBS.  Organ homogenates were serially diluted and plated
to determine the ratio of ΔtatC mutant CFU versus wild type HA431 from all of the
collected tissues of infected animals.  Data are expressed as the ratio of ΔtatC mutant
CFU versus WT CFU, and were normalized to the input ratio, converted logarithmically,
displayed graphically. Statistical significance was determined using a Student’s t test and
a P value of < 0.05.
Persistence in Salmonella Resistant CBA Mice
ΔtatC mutants (HA473) were tested for the ability to persist in the intestine of
Salmonella-resistant CBA/J mice in competitive infections with virulent ATCC14028
derivative HA431 (ΔphoN). Salmonella enterica serotype Typhimurium strains were
grown to stationary phase at 370C with aeration, and were mixed 1:1 prior to inoculation
and the precise titer of this mixture was determined by serial dilution and plating. 8-10
week old CBA mice were infected intragastrically by gavage with an equal mixture of
ΔtatC mutant and HA431, approximately 2x109 in 100 µl LB in groups of 4-6 mice.
92
Approximately 100 mg of feces were collected every three days for 40 days,
resuspended in 5 ml of sterile PBS, serially diluted and plated for enumeration of CFU
of ΔtatC mutant vs. WT (HA431). Data are expressed as the ratio of ΔtatC mutant CFU
versus wild type HA430, were normalized to the input ratio, converted logarithmically,
and displayed graphically. Statistical significance was determined using a Student’s t test
and a P value of < 0.05.
DOC Sensitivity
Sensitivity to bile acids was estimated by assaying sensitivity to 1% deoxycholic
acid [205]. Strains were grown to stationary phase at 370C with aeration and each strain
was diluted 1:100 into fresh LB broth and grown at 370C with aeration to exponential
phase. Exponentially growing cultures (OD600= 0.3-0.4) were serially diluted and spotted
in 3 µl spots on LB agar or LB agar supplemented with 1% DOC. Plates were incubated
overnight at 370C.
Motility Assays
Strains were tested for ability to swim on 0.3% agar Luria-Bertani (LB) plates or
swarm on 0.6% agar LB plates supplemented with 0.5% glucose, as previously described
[210]. Strains to be tested were spotted in equal amounts on the appropriate agar and
incubated at 370C for 5 or 7 hours, respectively and examined for motility.
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Flagellin Precipitation and Western Analysis
Flagellin production was analyzed under a variety of conditions. Strains were
initially grown in LB broth to stationary phase. A portion of the culture was used for
swimming and swarming motility assays, while the remaining cells from the 5 ml culture
were collected by centrifugation for 10 minutes at 4300 rpm in an Eppendorf 5804R
centrifuge. Swarming bacteria were collected from swarming motility plates by
swabbing the surface using a sterile cotton swab, resuspended in sterile PBS and
collected by centrifugation after determining the bacterial concentration by OD600.
Organisms were collected from plates used to assess swarming motility after 8 hours of
incubation. Bacteria were collected from swimming motility plates by collecting agar
plugs from inoculated swimming motility plates and the agar solids were removed by
filtering using a sterile porous paper (Kimax) and gentle pressure. The number of
bacteria in the filtrate was estimated by reading the OD600 and bacteria were collected by
centrifugation.
The pelleted bacteria from all growth conditions were resuspended in 1 ml of
sterile PBS and subjected to high- speed vortex for 5 minutes in order to shear the
flagellins from the bacterial surface [211]. After centrifugation, the supernatant was
removed and subjected to TCA (6% final concentration) precipitation on ice for 15
minutes [211,212]. TCA precipitated proteins were collected by centrifugation at 40C for
10 minutes at 13,000 rpm in an Eppendorf 5415R centrifuge and washed twice with 300
µl of acetone. Sheared precipitated proteins were resuspended in SDS-sample buffer.
The bacterial pellet was also treated with 100 µl of SDS-sample buffer.
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Sheared, TCA precipitated samples and whole cell lysates were boiled for 10
minutes in SDS-PAGE loading buffer, separated on SDS-PAGE  (7.5% running gel,
4.5% stacking gel), and transferred to PVDF membrane using standard Western blotting
protocols [213]. Membranes were blocked with 5% (wt/vol) non-fat dry milk in PBS
containing 1% Tween (PBST) for 1 hour at 250C and probed with rabbit α-FliC (Becton
Dickson, Difco Salmonella H Antiserum i) at a dilution of 1:10,000 or α-FljB (Becton
Dickson, Difco Salmonella H Antiserum Single Factor 2) at a dilution of 1:1,000
overnight at 40C in blocking solution. Blots were washed three times in sterile PBST for
10 minutes. Alkaline phosphatase-conjugated secondary α-Rabbit IgG (Sigma) was used
at 1:10,000 in 5% (wt/vol) non-fat dry milk in PBST on blots for 1 hour at 25oC. Blots
were washed three times in PBST followed by addition of the Immune-Star AP substrate
(Bio-Rad) for 5 minutes.
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CHAPTER IV
SUMMARY AND CONCLUSIONS
Summary
ABACUS
Targeted deletion by lambda-red recombination was previously used to construct
a library of specific gene deletion mutants for E. coli [166]. Here, we use this approach
for Salmonella, and modify it by adding a T7 RNA polymerase promoter to the insert for
the generation of unique transcripts from each mutant. These transcripts are used to
identify and measure the relative abundance of each mutant from a pool containing all of
our mutants. Furthermore, we introduce several technical innovations to improve the
throughput of library construction, and the labeling and detection of transcripts from
each mutant on an inexpensive, customized microarray. We use a well-studied model,
systemic infection of BALB/c mice, to validate our assay and identify additional
candidate genes that affect the fitness of Salmonella in that infection model.
Our targeted deletion strategy has several important advantages over screening of
pools of mutants made by random transposon mutagenesis. Screening targeted deletion
pools reduces the complexity of the bacterial pool necessary to cover all genes of interest
by at least 10-fold over random transposon mutant pools; mathematically, 40,000
random transposon mutants cover about 90% of all non-essential Salmonella genes,
whereas 4,000 specific mutants in each non-essential gene provides 100% coverage of
the targeted genes. This less complex pool is highly advantageous for forward genetic
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strategies in circumstances where population sizes drop during the selection process,
such as in animal models [163,214,215,216,217]. For Salmonella, this “bottleneck” is
particularly severe in the transition from the intestinal tract to the systemic circulation
[218,219] and perhaps in different parts of the gastrointestinal tract where niche
conditions can vary considerably. These bottlenecks cause random loss of mutants from
the pool if the population falls to numbers close to the complexity of the interrogated
pool. For example, if a population falls transiently to 40,000, then a pool of 40,000
mutants will lose about 37% of its members at random whereas a pool of 4,000 should
not lose any mutants (P<0.01 for loss of one mutant). Furthermore, a pool of lower
complexity may be used at a lower infectious dose, allowing a more physiologically
relevant infection. The smallest possible pool that includes each mutant of interest is
therefore highly desirable.
In any particular experimental system the size of the inoculum needed to avoid
bottlenecks will have to be determined empirically.  It is possible to determine the
optimum size of the inoculum and ascertain whether or not there is a bottleneck by
including a “neutral” mutant carrying a different antibiotic marker at the same CFU as
the average mutant CFU in the pool in each experiment. If the representation of this
marked strain varies dramatically (either highly over- or under-represented) in the
recovered samples in this “fluctuation test”, then the inoculum is of insufficient size to
prevent random loss from a pool of that complexity (McClelland et al., unpublished
data).
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Random transposons can generate pronounced downstream effects that
contribute to selection. Our targeted in-frame deletions are engineered to minimize or
eliminate these effects. Desirable existing features of the cassette inserted by lambda-red
recombination [157], such as an internal ATG start codon at the end of the inserts to
allow downstream translational coupling, and the inclusion of FRT sites for the removal
of the antibiotic cassette by FLP recombination, remain intact. In our construct, FLP
recombination results in the production of an in-frame mini-protein, while retaining the
PT7, that uses the original start and stop codons of the deleted protein. The first and last
30 bases of each targeted gene were maintained to reduce the chance that targeted
deletions disrupt adjacent genes, overlapping genes, and cis-acting sequences thus
further minimizing the risk of polar effects. Subsequent analyses should consider that in
rare cases the remaining mini-protein may retain some function. Finally, an advantage of
this collection of specific deletion mutants is that confirmation of mutants identified by
genetic screening requires the generation of targeted mutations. A targeted deletion
library allows independently generated mutants in the gene of interest to simply be
picked from the ordered collection of mutants for further analysis.
Earlier labeling strategies for T7 transcripts from transposon libraries use
restriction digestion to fragment the genomic DNA, which has the effect of producing
shorter labeled transcripts that are easily mapped near the PT7 [160,161,163,168]. This
approach results in non-uniform labeling of transcripts, because those transposons that
are not in the ideal proximity to a restriction site are poorly sampled. Our labeling
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strategy uses randomly sheared ends, resulting in more uniform and consistent labeling
efficiency for every mutated gene.
The presence of a PT7 promoter in each targeted mutant allows the presence and
the level of each individual mutant to be tracked when mutants are pooled, using the
mutant-specific transcript produced from this promoter. This innovation eliminates the
need to introduce a different ‘signature’ sequence in each of the mutants in the
collection. The PT7 facilitates efficient RNA synthesis only from those DNA fragments
that contain PT7. Any artifacts that might be generated during the tailing and PCR steps
are not transcribed. Note that our PT7 procedure generates primarily single stranded
labeled RNA, minimizing competition for hybridization to the oligonucleotide array.
The performance of this protocol was consistently superior to direct labeling of PCR
products as measured by microrray (data not shown).
The presence of the T7 RNA polymerase promoter in each mutant construct
allowed us to check all candidate mutants simultaneously for the location of a functional
PT7. Using a NimbleGen tiling array of 387,000 oligonucleotides, we confirmed 933 of
1031 mutants in the Kan R pool as present in exactly the correct place, and functional,
simultaneously. Similarly, 892 of 972 CmR mutants were confirmed using this technique.
Thus, we bypassed much more expensive and laborious traditional PCR confirmation.
We also confirm the activity of the PT7, which is not possible using PCR.
For routine hybridizations of the pool, we constructed an inexpensive
oligonucleotide microarray using the same oligonucleotides that we used to construct the
mutants, containing 45 bases of homology to the Salmonella genome. This array could
99
also be used to confirm the presence of nearby active PT7 in a pool. However, unlike the
NimbleGen array, this minimal array does not prove the location of the inserted
cassettes, or find extraneous insertions that occur elsewhere in the genome. Fortunately,
the more expensive NimbleGen arrays need only be used once to determine which
mutations are in the correct location and have an active PT7. After the library is
characterized, the less expensive in-house arrays can be used for further experiments
without ambiguity.
In order to test our targeted deletion collection and novel protocols, we used
systemic infection of BALB/c mice, a model system that has been studied extensively
using transposon libraries [126,129,136,137,162]. All the mutants in our collection that
were reported to have attenuated growth in these previous transposon assays were
confirmed in our assay, including those in SPI-2 and lipopolysaccharide biosynthesis
genes. In addition, among the 120 mutants showing the strongest fitness phenotype we
identified 51 candidates with no previously known phenotype in this model (Table 2),
although many of these new candidate phenotypes are generally more subtle than those
seen for SPI-2.
We retested sixteen of the novel mutants, including ΔtatC, with at least a 2-fold
change in representation between the input and output pool (P<0.0001) in individual
competitive infections, and eleven were confirmed in mutants containing the antibiotic
cassette. We retested eight of these mutants (in STM1131, STM2303, STM3120,
STM3121, sroA, istR, leuX and oxyS) after removal of the antibiotic resistance cassette,
and the phenotype remained in all eight of these mutants (Figure 9 and Table 3). We
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complemented two of these novel mutants, in STM2303 (pmrM) and STM3121 (a LysR-
type transcriptional regulator), with the corresponding intact open reading frames in
trans. We observed reversal of the mutant phenotype for both of these mutants in
competition assays with wild type (Figure 10), thus directly and unambiguously linking
the observed phenotypes to these genes. These results suggest that most of the remaining
25 top mutants of the original 40 novel candidates that we identified may have a
phenotype in this BALB/c acute systemic infection model, and there may be additional
mutants yet to be discovered.
Using our method, the overall false negative rate (failure to observe phenotypes
for mutants already known to be under strong selection in this model) was zero. Among
120 mutants showing a phenotype with P<0.0001 and a greater than two-fold change,
more than half are already known to have a phenotype and among the new candidates,
eleven out of fifteen were confirmed. Thus, the false discovery rate is very low.
However, the false discovery rate for new mutants in a system that is already well
studied is invariably high. When most genes with a role in a process are known, only a
few phenotypes remain to be discovered among the thousands of genes that have no
phenotype in that process. The future rate of discovery in the intraperitoneal model in
BALB/c mice, is unlikely to be better than the rate of 11 out of 15 that we experienced.
The rate of confirmation of mutants that show a weaker statistical confidence and lower
fold-difference in fitness will likely be very poor. In addition, those mutants with subtle
phenotypes in an animal, that in the past have included important genes such as TTSS
effectors will require a larger number of biological replicates in order to establish the
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phenotype with confidence. Other phenotypes that will be missed by using a pool of
mutants are any that are suppressed by the presence of wild-type bacteria.
Of the mutants we confirm in individual competitive infections, four were in
small RNA molecules. Mutations in leuX, encoding a minor tRNA-Leu, were previously
known to reduce the expression of Type I fimbriae due to codon usage, and reduce
bladder epithelial invasion and intracellular proliferation of Uropathogenic E. coli
[220,221]. The attenuation of a leuX deletion during Salmonella infection was previously
unknown. Mutants in the regulatory sRNAs IstR, OxyS and SroA showed small, but
reproducible, phenotypes in our in vivo experiment, and all have orthologs in E. coli. In
E. coli, IstR inhibits the translation of tisAB, an SOS-induced toxic peptide, and may
arrest growth allowing DNA repair [222,223,224,225]. SroA is a known regulator of the
thiBPQ operon in E. coli, that encodes an ABC transport system for the import of
thiamine and thiamine pyrophosphate (TPP) into the cell [226]. TPP is an essential
cofactor for key enzymes in carbon metabolism.
The oxyS mutant was one of the few examples of a mutant that displayed an
increase in fitness in vivo in our screen. OxyS is a member of the OxyR regulon
expressed during oxidative stress. This sRNA is a pleiotropic regulator of about 40 genes
in E. coli including rpoS, and an anti-mutator that may inhibit alternate stress adaptation
pathways when OxyR is activated [225,227]. Our observations for OxyS, SroA, and
IstR, are the first examples of phenotypes for small non-coding RNA mutants during
Salmonella infection, other than the tmRNA system that targets proteins for degradation
[228].  The targets of these sRNAs in Salmonella are not fully known, and given, for
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example, the recently reported variable composition of the PhoP regulon across related
organisms [229], may differ significantly from their targets in related organisms.
Of the seven remaining confirmed mutant phenotypes, four are in genes that
encode putative membrane proteins (STM1131, STM2120, STM2215 and STM2303), and
a fifth gene (STM1760) encodes a putative secreted protein. STM1131 encodes a member
of the KdgM superfamily (oligogalacturonate-specific porin). A paralog of this gene,
STM4016 (yshA, 26% identity, 40% similarity) is involved in O-Antigen capsule
production and environmental persistence [230]. Mutants in a second membrane protein,
STM2120 (asmA), are highly sensitive to gastric contents of swine, but otherwise little is
known of the function of this gene in Salmonellae [151]. Mutants in the E. coli orthlog
of asmA are extragenic suppressors of outer membrane protein assembly and have less
LPS on the bacterial surface [231]. A third gene encoding a predicted membrane protein,
STM2215, is one of at least eight proteins encoded by Typhimurium that contain cyclic-
di-GMP phosphodiesterase, or EAL domains (named after the amino acids in the
conserved domain). Unlike several other EAL-containing proteins, mutations in
STM2215 do not influence a multicellular behavior known as the rdar morphotype [232].
Our work reports the first phenotype of any kind for STM2215.
Finally, STM2303 (pmrM; pbgE3) is the terminal gene in the pmr operon
(polymyxin resistance) and also encodes a predicted membrane protein. This operon is
involved in 4-aminoarabinose addition to Lipid A, a modification that confers resistance
to polymixin [233]. Paradoxically, PmrM does not appear to be necessary for this
function [233,234], but may be important for resistance of Salmonella to high iron
103
concentrations in vitro [235,236]. Recent studies show that mutants in STM2303 have
reduced expression of hilA, an important regulator of virulence genes in Salmonella, and
reduced invasion in T84 human colonic epithelial carcinoma cells [237].
Mutants in STM1760, encoding a protein containing a classical N-terminal
secretion signal sequence, were also confirmed as selected against in our competitive
infection assays. The protein encoded by this gene contains multiple Tricopeptide
Repeats (TPR) of the Sel-1 superfamily, a motif that mediates protein-protein
interactions [238]. Nothing further is reported in the literature about this protein and its
potential role during systemic infection by Salmonella.
The final genes we confirmed to be important during systemic infection in
BALB/c mice, STM3120 and STM3121, are neighboring in the genome.  STM3121 is a
LysR family transcriptional regulator neighboring STM3120 but is transcribed in the
opposite direction. Interestingly, expression of STM3121 in trans appeared to increase
fitness during infection (Figure 10). STM3121 has not previously been reported to be
important during Typhimurium infection, and determination of its regulatory targets may
reveal clues as to its role during infection.
STM3120 and several adjacent genes (cluster STM3120-STM3117) are present in
serotypes Typhimurium, Enteritidis, and Gallinarum [159] and in some Yersinia [239],
but are not present in the typhoidal Salmonellae or other enterobacterial species studied
to date. A second gene in this group, STM3119, was also selected against during our
ABACUS screen. Proteomic and transcriptional data indicates that the proteins encoded
in this region are highly up-regulated in macrophages [119,120,240]. In serotype
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Enteritidis, these genes are essential for growth in chicken macrophages and mutants in
some of these genes in Gallinarum are defective for systemic colonization after oral
infection in chickens [159,241].
Although STM3120 is a predicted citE (citrate lyase) homolog, the other two
subunits (citD encoding the a-subunit, and citF encoding the g-subunit) that normally
make up bacterial ATP-dependent citrate lyase are not encoded in the region containing
this gene. This suggests that STM3120 may have a different function than a traditional
citrate lyase. In Yersinia pestis, homologs of STM3120-3117 are necessary for survival
in macrophages that are activated with IFN-γ after infection. These genes appear to
function in Y. pestis by lowering the level of nitric oxide in macrophages without
affecting iNOS levels in g-interferon post-treated macrophages [239]. It is possible that
these genes play a similar role in Salmonella, but this hypothesis remains to be
investigated.
To summarize, we have designed a collection of novel technologies that permit
easy generation and confirmation of specific deletion mutants for genetic screening, both
individually and in pools. Use of our collection, designed to minimize the effects of
population bottlenecks on screening, will allow relevant animal models and more
relevant doses to be efficiently used to identify Salmonella mutants with altered fitness
in vivo. During our testing of this approach, eleven of such mutants were confirmed in
individual competition assays, including three sRNAs and leuX. The tools used here are
a first step to a more complete description of Salmonella genes involved after systemic
delivery in mice, particularly those genes with milder phenotypes that were difficult to
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identify with confidence in previous studies. These tools are also of wide applicability to
identify genes involved in other aspects of Salmonella biology. Finally, similar strategies
can be applied in other genetically malleable bacteria.
TatC
Gram negative organisms secrete folded proteins across the inner membrane
using the twin arginine transport (Tat) system
[184,192,242,243,244,245,246,247,248,249]. Disruption of the Tat system results in a
range of defects in diverse processes including transport of virulence determinants, cell
division, motility and chemotaxis. In E. coli 0157:H7, Tat mutants have attenuated
toxicity to Vero cells, and they have motility defects [244]. In Yersinia
pseudotuberculosis, a functional Tat system is necessary for virulence, motility and acid
resistance [243].  In Vibrio cholerae, mutants in the Tat system are impaired for
intestinal colonization in the infant mouse model and have reduced ability to form
biofilms [249], but do not have motility defects. In Pseudomonas aeruginosa, an intact
Tat system is necessary for transport of virulence determinants, such as phospholipases,
and is also involved in iron uptake, stress defense, motility and biofilm formation
[245,246]. Some gram-negative organisms, such as Mycobacterium tuberculosis, rely on
a functional Tat system for the secretion of beta-lactamases for antibiotic resistance
[247,248]. The number and complement of proteins predicted to be secreted by the Tat
system is highly variable between organisms [197], and this may be one factor that
influences the multiple and varied phenotypes of Tat mutants.
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 Tat mutants in Salmonella enterica serotype Typhimurium ATCC14028 also
display multiple defects. We determined that ∆tatC mutants in Salmonella are defective
for growth in systemic organs after intraperitoneal infection, a route of infection that
bypasses the intestinal tract. Because macrophages are an essential niche for serotype
Typhimurium during systemic infection in mice, we tested the ability of ∆tatC mutants
to associate with and become internalized by macrophages. The ability of ∆tatC mutants
to associate with, be internalized by, and replicate in J774-A.1 was reduced as compared
to the isogenic wild type.
Tat mutants in other pathogenic bacteria also associate poorly with or replicate to
lower numbers in eukaryotic cells.  In Vibrio cholera, mutants in the Tat system attach
poorly to HT-29 cells [249]. Legionella pneumophila Tat mutants have defects in
intracellular replication within differentiated U937 cells during later stages of growth
[250]. In E. coli, ΔtatC  mutants have been have a mutant cell septation phenotype and
thus form long chains of bacteria [202]. The reduced internalization of Salmonella Tat
mutants by cultured macrophages may actually be difficulty in phagocytosis, as long
chains of bacteria may not be easily phagocytosed by macrophages.
We also show that ∆tatC mutants are defective for intestinal colonization after
oral infection of both Salmonella-susceptible BALB/c mice and Salmonella-resistant
CBA/J mice. Similar defects in intestinal colonization have previously been shown for
Tat mutants in other gram negative pathogens including Vibrio cholera [249], Yersinia
pseudotuberculosis [243], and Camplyobacter jejuni [251] We further show that ∆tatC
mutants are extremely sensitive to 1% Deoxycholic acid (DOC) in vitro, an assay
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commonly used to test for increased sensitivity to bile acids [205]. This sensitivity is
likely a contributing factor for the reduced ability of Salmonella ∆tatC mutants to
colonize the murine intestine. Tat mutants in E. coli and C. jejuni have also been shown
to have increased sensitivity to detergent and choleate [202,203,204,251,252].
Finally, similar to Tat mutants in other organisms [243,244,245,251], Salmonella
∆tatC mutants have a strong defect in swimming motility, as a result of failing to export
flagellins under conditions that allow swimming motility. We show that Tat mutants are
able to export flagellins to the surface and that these mutants are motile under conditions
that promote swarming motility, unlike Tat mutants in Pseudomonas [245]. Thus
Salmonella Tat mutants are not non-motile under swimming conditions because they do
not export flagellins to the bacterial surface under these conditions. Similarly, Tat
mutants in several other organisms, including Agrobacterium and Pseudomonas, were
shown to be non-motile but to be able to produce flagella in a small proportion of the
population [245,253].
The mechanism responsible for the inability of Tat mutants to produce flagella
has not yet been determined, but several hypotheses have been proposed. In ΔtatABC
mutants of E. coli O157:H7 the inability to export FliC is hypothesized to be due to
impaired insertion of FliP into the outer membrane [244]. The FliOPQR operon encodes
class 2 flagellar proteins that make up part of the MS ring of the flagellar export system,
and they are necessary for the export of flagellins[254]. FliP contains a cleavable signal
sequence (MRRLLFLSLAGLWLFSPAAAA) with a twin arginine motif, necessaryfor
its insertion into the cytoplasmic membrane [255,256] . However, the twin arginine
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motif in the FliP signal sequence is not recognized by either the TatP or TATFIND
signal recognition software and FliP has not been shown experimentally to be secreted
via the Tat system [197,257].
Also, elimination of FliP secretion when the Tat system is inactivated seems an
implausible mechanism for the defects in swimming motility and flagellar export of
Salmonella Tat mutants under swimming conditions, because we show that these
mutants are still motile and able to secrete flagellins in swarming conditions. FliR, which
acts in conjunction with FliP for the export of flagellin [256] was previously shown to be
up regulated in ΔtatC mutants in E. coli under anaerobic conditions [207]. The effect on
flagellins appears to be coordinated with environmental cues, and is likely to be more
complex than was previously hypothesized.
The integrity of cell envelope of ΔtatC mutants has been shown to be impaired in
E. coli [204], P. aeruginosa [245], and we show that Salmonella Tat mutants are
sensitive to the detergent DOC (Figure 4).  In ΔtatC mutants in E. coli, the Rcs regulon
(regulator of capsule synthesis) is up-regulated in response to cell envelope defects. This
regulon has also been shown to inhibit flhDC leading to impairment of motility [206]. It
is possible that the defects in motility of ΔtatC mutants are an indirect effect of increased
Rcs activity. We show that deletion of rcsB in a ΔtatC background is able to partially
rescue both the swimming defect and the flagellar export defect. One possible
interpretation of this data is that under swimming conditions a signal is necessary to
remove rcsB from the promoter region of flhDC and this signal is not necessary under
swarming conditions.
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In this work, we show that ΔtatC mutants do not survive well in the intestinal
tract or in systemic sites during experimental infections. Defects in the ability of ΔtatC
mutants to survive antimicrobial defenses, such as bile, affect survival during intestinal
infection, and inability to survive within macrophages during systemic infection
contribute to the survival of ΔtatC mutants during infection. Though not yet shown
experimentally, there may also be a link between the ability to express flagellins on the
surface of Salmonella under different conditions with the ability to survive in those
conditions, for example, perhaps escaping innate immune detection during infection.
These factors, along with the ubiquitious nature of the Tat system, make the twin
arginine transport system a viable target for drug development.
Conclusions
We have developed an array-based method, which we used to identify mutants
defective during systemic infection with Salmonella enterica serotype Typhimurium.
Novel data generated from this screen will further our understanding of virulence
mechanisms and potentially lead to development of increasingly well-defined drug
targets. Future work will include completion of the deletion library consisting of single
mutants, as well as large island deletions. Our lab will continue to follow novel data
generated from the systemic model, but will also focus on mutants defective in intestinal
persistence in orally infected animals. The tools developed during this work provide
great promise for the future of our understanding of Salmonella pathogenesis.
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